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ABSTRACT 
Rats were exposed to continuous inhalation of ethanol 
vapors in an inhalation chamber plus daily injections of an 
alcohol dehydrogenase inhibitor pyrazole (68 mg/kg, i.p.). 
Ethanol vapors entered the inhalation chamber at flow rates 
of from o.45 liters/min. to 0.95 liters/min. which when 
mixed with a constant stream of air (5.0 liters/min) pro-
duced chamber concentrations of from approximately 8.8 mg/ 
liter to 26.5 mg/liter. Rats exposed to these conditions 
for 5 to 7 days developed blood ethanol levels of 0.8J± 
0.09 mg/ml/blood to 2.19 ± 0.14 mg/ml/blood. Administra-
tion of pyrazole with or without ethanol caused weight loss 
in these rats. Rats developed tolerance to ethanol after 
continuous inhalation of ethanol vapors for 5 days demon-
strated by increased onset and decreased duration of etha-
nol-induced narcosis. After 5 days of continuous ethanol 
inhalation rats became physically dependent on ethanol and 
developed withdra wal signs of piloerection, abnormal pos-
ture, tremors, convulsions, headshakes, tail-lifts and mor-
tality upon cessation of ethanol administration. The four 
withdrawa l signs of piloerection, abnormal posture, tremors 
and convulsions were combined into an ethanol withdrawal 
syndrome measurement. Pretreatment of ethanol dependent 
rats JO minutes prior to J6 hours of ethanol withdrawal, 
the period of maximum int e nsity of the withdrawal syndrome, 
ii 
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with ethanol (2.0 g/kg, orally), chlordiazepoxide (40 mg/ 
kg, i.p.) or morphine (10 mg/kg, i.p.) significantly re-
1 
duced the intensity of the ethanol withdrawal syndrome as 
measured during the thirty-sixth hour of ethanol withdrawal. 
Rats withdrawn after continuous inhalation of ethanol vapors 
showed intense aggression (attacks and bites, rearing and 
vocalizations) after small doses of apomorphine (2 . 5 mg/kg, 
i.p.) or ct-amphetamine (2.0 mg/kg, i.p.), although little 
spontaneous aggression was seen. Other ethanol withdrawal 
signs returned to near control levels by 72 hours after 
ethanol withdrawal, however drug-induced aggression was 
present for at least 7 days after ethanol withdrawal. Ad· 
ministration of ethanol (4.0 g/kg, orally), chlordiazepox-
ide (80 mg/kg, i.p.) or morphine (10 mg/kg, i.p.) JO min-
utes prior to apomorphine administration (2.5 mg/kg, i.p.) 
significantly reduced apomorphine-induced aggression in 
ethanol withdrawn rats. During withdrawal from ethanol, 
mortality was 20% among rats exposed for 5 days to ethanol 
inhalation and not treated with any drugs during' withdrawal . 
None of the drugs used in this study significantly reduced 
the mortality rate in ethanol withdrawn rats . However, ad-
ministration of chlordiazepoxide (160 mg/kg, i.p.) prior to 
the thirty-sixth hour of ethanol withdrawal resulted in a 
signifi cant increase in the mortality to 75%. This same 
dose of chlordiazepoxide administered intraperitoneally to 
untreated rats resulted in a mortality of 66.7% of the rats 
treated within 36 hours after injection. 
ACKNOWLEDGEMENTS 
I would like to express my sincere gratitude to my wife, 
Sharon and my daughter, Dana, for their understanding and 
patience without which this would not have been possible. 
I would also like to express my appreciation to Dr. 
Harbans Lal for his guidance throughout this study. I would 
also like to acknowledge Dr. Alvin K. Sw~nger and the other 
members of my committee for their advice and assistance. 
Also, I would like to make special acknowledgement to 
Dr. William D. Lawing for his expert statistical advice. 
I am also grateful to the faculty of the Department of 
Pharmacology and Toxicology for their helpful suggestions 
during this study. 
The financial aid provided through a teaching assistant-
ship by the Department of Pharmacology and Toxicology is 
gratefully acknowledged. 
iv 
ll 
, · 
,, 
.__"""'"'·· ------ ~-- .......... ...i...---~- -
---· j ;1 ' ___ :.::_ _______ _ 
.ABSTRACT •••••• 
ACKNOWLEDGEMENI'S. . 
TABLE OF CONTENfS • . 
LIST OF TABLES 
LIST OF FIGURES 
INTRODUCTION 
LITERATURE SURVEY • 
TABLE OF CONTENTS 
Alcoholism As An Addiction . 
Ethanol Tolerance .... 
Metabolic Tolerance . . • 
Cellular Tolerance ... 
Ethanol Dependence . . . . . . . . • . . . . 
Hypomagnesemia and Respiratory Alkalosis .... . 
Sleep Disturbances ........... . 
Denervation Supersensitivity .....•.... 
Mechanisms of Tolerance and Physical Dependence. 
Enzyme Expansion Theory . . . . . . . . . 
Increased Receptor Sites ...............• 
Acetaldehyde, Alcohol and Biogenic Amines 
Assessment of Ethanol Tolerance ..... . 
Assessment of Ethanol Withdrawal ... . 
Oral and Intragastric Administration. . . • . . 
Intravenous Administration 
Inhalation Administration . . . 
Alcohol and Pyrazole . . . . 
Treatment of Ethanol Withdrawal. . 
Specific Treatment of Acute Alcohol Withdrawal. 
Ethanol in the Treatment of Alcohol Withdrawal. 
Comparison of Major and Minor Tranquilizers in Acute 
Alcohol Withdrawal ..•. 
Withdrawal Aggression . . . . . . . . • . 
EXPERIMENTAL. 
Animals .. 
Materials. 
Ethanol Vapor Chamber. 
Determination of Ethanol-Vapor 
Determination of Blood Ethanol 
v 
. . . . . 
Concentrations .. 
Levels ..... 
.· 
·. ~· 
Page 
ii 
iv 
v 
vii 
viii 
1 
7 
7 
8 
8 
8 
9 
10 
11 
12 
13 
14 
15 
15 
21 
22 
23 
25 Ji 
27 ""' 
28 
29 
29 
30 
31 
33 
34 
34 
34 
35 
35 
38 
Ethanol Intoxication. 
Ethanol Tolerance 
Ethanol Withdrawal 
Withdrawal Aggression 
Statistical .Analysis. 
RESULTS 
DISCUSSION 
SUMMARY. 
APPENDIX I 
APPENDIX II. 
APPENDIX III 
APPENDIX IV. 
REFERENCES 
VITA . 
, I', 
~·-~·.'..:-!. 
vi 
Page 
39 
46 
46 
47 
48 
49 
97 
118 
120 
124 
127 
130 
133 
LIST OF TABLES 
TABLE 
1 Blood Ethanol Levels in Rats Inhaling Ethanol Vapors •• 
2 Effect of Pyrazole or Ethanol plus Pyrazole on Ethanol-
Induced Narcosis. . . . . . . . . . . . . . 
. . ~ ' 
3 Ethanol Withdrawal Intensity Rating Scale . 
4 Effect of Pyrazole on the Body Weight of Rats Inhaling 
Ethanol . . . . . . . . . . . . . . . . . . . . . . . 
5 Effect of Ethanol Upon the Frequency of Headshakes. 
Page 
43 
51 
53 
56 
70 
6 Effect of Ethanol Upon the Frequency of Tail-Lifts. 71 
7 Effect of Chlordiazepoxide Upon the Frequency of 
Headshakes. . . . . . . . . . . . . . . . . . . . 7 4 
8 Effect of Chlordiazepoxide Upon the Frequency of Tail-
Lifts . . . . . . . . . . . . . . . . . . . . . . . 75 
9 Effect of Morphine Sulfate Upon the Frequency of Head-
shakes . . . . . . . . . . . . . . . . . . . . . . . . 78 
10 Effect of .M:>rphine Sulfate Upon the Frequency of Tail-
lifts . . . . . . . . . . . . . . . . . . . . . . . 80 
11 Effect of the Duration of Ethanol Withdrawal on Apo-
morphine- Induced Aggression . . . . . . . . • . . . . 81 
12 Apomorphine- Induced Aggression in Ethanol Withdrawn Rats. . 83 
13 Amphetamine-Induced Aggression in Ethanol Withdrawn Rats. 
14 Drug- Induced Aggression in Seven-Day Ethanol Withdrawn 
Rats ........................ . 
15 Reduction of Apomorphine-Induced Aggression by Ethanol. 
16 Reduction of Apomorphine-Induced Aggression by Chlordi-
azepoxide . . . . . . . . . . . . . . . . . . . . . . . 
17 Reduction of Apomorphine-Induced Aggression by Morphine 
Sulfate . . . . . . . . . . . . . . . . . . . . . . 
18 Mortality During Ethanol Withdrawal in Untreated Rats 
and Rats Administered Ethanol, Chlordiazepoxide or 
Morphine During Ethanol Withdrawal ......... . 
vii 
86 
89 
90 
92 
93 
95 
I 
". -- -~ --·--'"-- _....._.......___...._ _____ ___._. ___ , _____ _ 
LIST OF FIGURES 
FIGURE Page 
1 Enzyme Expansion Theory. • 14 
2 Proposed Pathway for In Vivo Synthesis of 
Morphine-Like Alkaloids. • 18 
J Structures of Tetrahydroisoquinoline Alkaloids 
Formed from Catecholamines by Condensation 
with Aldehydes • • 19 
4 Relationship Between Ethanol Flow-Rate and 
Chamber Ethanol Vapor Concentration. • 37 
5 Standard Curve for Quantitative Determination 
of Ethanol in Blood . • 40 
6 ' Relationship Between Chamber Ethanol Vapor 
Concentration and the Mean Blood Ethanol Levels 
of Rats Inhaling Ethanol • • 44 
7 Relationship Between the Cumulative Doses of 
Pyrazole and the Mean Blood Ethanol Levels 
of Rats Inhaling Ethanol • • 45 
8 Effect of Three Ethanol Exposure Protocols on 
the Intensity of the Ethanol Withdrawal 
Syndrome . • 54 
9a Ef fect of Withdrawal Duration Upon the In-
tensity of Ethanol Withdrawal Signs in Rats 
Withdrawn from Inhalation of Ethanol Vapor • • 58 
9b Effect of Withdrawal Duration on the Intensity 
of Ethanol Withdrawal Signs. • 60 
10 Effect of the Duration of Ethanol Withdrawal. 
on the Occurrence of Headshakes. 
11 Effect of the Duration of Ethanol Withdrawal 
• 62 
on t he Occurrence of Tail-Lifts . • 6J 
12a Reduction of Ethanol Withdrawal Signs by 
Orally Administered Ethanol. • 65 
lJ Dose-Dependent Effect of the Ethanol With-
drawal Syndrome by Orally Administered Ethanol • 67 
viii 
FIGURE 
14 Dose-Dependent Effect of the Ethanol With-
drawal Syndrome by Intraperitoneally Ad-
ministered Chlordiazepoxide. 
15 Dose-Dependent Effect of the Ethanol With-
drawal Syndrome by Intraperitoneally Ad-
ministered Morphine Sulfate. 
Page 
73 
77 
INTRODUCTION 
In man, alcohol dependence usually evolves over many 
years and consequently, its developmental antecedents are 
obscured by time. It has generally been agreed that de-
velopment of an alcohol dependent animal would permit the 
study of the addictive process. Indeed several animal 
models of ethanol physical dependence have been reported. 
The methods used were schedule-induced polydipsia (Falk, 
1972), liquid diets containing ethanol (Freund, 1969; 
Branchey et al., 1971; Pieper et al., 1972; Pieper and 
Skeen, 1972), gastric or nasogastric intubations (Majch-
rowicz, 1973; Ellis and Pick, 1970b.; Essig and Lam, 1968), 
intravenous administration (Deneau et al., 1969; Winger et 
al., 1970) and inhalation with or without pyrazole (Gold-
-.-
stein and Pal, 1971; Littleton et al., 1974; Roach!:.! al., 
1973). The inhalation technique has proved to be most ap-
plicable for experimental studies and has been used for 
testing the effects of drugs on the ethanol withdrawal re-
action (Goldstein, 1972b.; 1973). The evidence indicates 
that maintainance of consistently high blood ethanol levels 
for several consecutive days is necessary for production 
of ethanol physical dependence (Mello and Mendelson, 197la; 
197lb.). Majchrowicz (1973) and Roach et al. (1973), out-· 
lined the withdrawal signs in rats. Although, comprehen-
1 
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sive behavioral rating scales have been developed for mice 
2 
(Irwin, 1968; Goldstein, 1972a.; Freund, 1969) few have been 
developed for other species and none for the rat (Mello, 
1973). 
Behavioral tolerance to alcohol in alcoholics has been 
demonstrated (Isbell et al., 1955; Newman, 1941). However, 
the biochemical mechanisms underlying tolerance to ethanol 
are unknown. Metabolic tolerance to alcohol in animals 
(Hawkins et al., 1966) and man (Mendelson et al., 1966) has 
been shown, however metabolic changes cannot adequately ex-
plain the tolerance seen in animals or man (Mendelson, 1971; 
Mello 1972; LaBlanc et al., 1969) and a role for cellular 
adaption in the central nervous system is necessary. 
The mechanisms underlying the expression of withdrawal 
signs upon cessation of ethanol administration are unknown. 
Roles for hypomagnesemia and respiratory alkalosis (Victor, 
1973), sleep disturbances (Gross et al., 1974), and denerva-
t i on supersensitivity (Jaffe and Sharpless, 1968) have been 
proposed as relating to the expression of withdrawal signs. 
Theories about the underlying mechanism involved have in-
eluded enzyme repression and derepression (Goldstein and 
Goldstein, 1967), increased receptor sites (Collier, 1965), 
fo r mation of morphine-like alkaloids within the central 
nervous system (Walsh et al., 1970), formation of false 
adrenergic transmitters (Cohen, 1973a.; 1973b.) and inhi-
bition of nerve impulses (Wallgren, 1973; Tabakoff et al. , 
1973). 
J 
Treatment of the acute alcohol withdrawal syndrome has 
been reviewed by Gross et al. (1974). Goldstein (1972b.), 
compared several drugs in the treatment of ethanol withdraw-
al signs including ethanol, chlordiazepoxide, promazine and 
barbiturates. It has been shown that ethanol does act as 
expected in reducing the withdrawal severity of alcohol de-
pendent and withdrawn animals (Goldstein, 1972b.; Ellis and 
Pick, 1972b.), although such treatment in man is not ad-
vised (Isbell et al., 1955; Golbert ~al., 1967). Chlor-
diazepoxide is considered one of the most effective treat-
ments for delirium t~emens (Gross et~., 1974; Favazza and 
Martiri, 1974) and is effective in animals as well (Gold-
stein, 1972b.). 
The use of haloperidol in the treatment of acute alco-
hol withdrawal has been studied, although not extensively 
(Gross~ al., 1974), however morphine has not been reported 
in the treatment of acute alcohol withdrawal. Gross et al. 
(1974), presented evidence that haloperidol is at least as 
effective as paraldehyde or chlordiazepoxide in reducing 
withdrawal severity during the first 48 hours of alcohol 
withdrawal in man. It has been proposed that ethanol, via 
its metabolite acetaldehyde, may cause formation of mor-
phine-like alkaloids in the central nervous system (Walsh 
~al., 1970) and that acute morphine administration blocks 
dopamine receptors similar to haloperidol, but, is less 
potent (Puri~ al., 197J). Therefore, the use of ethanol, 
< ' ----~~~~~~--
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chlordiazepoxide and morphine in the treatment of acute al-
cohol withdrawl in rats is of scientific interest. 
Rats made physically dependent on morphine show spon-
taneous aggression during withdrawal without any other 
stimulation (Puri and Lal, 1973). This spontaneous aggres-
sion is enhanced by administration of apomorphine or amphet-
amine and is blocked by the narcotic methadone and the dop-
amine receptor blocking neuroleptic haloperidol (Puri and 
Lal, 1973). It has also been shown that chronic haloperidol 
administration increases the sensitivity of rats to induction 
of aggressiori by small doses of apomorphine (Gianutsos et 
al., 1974a.). Apomorphine is a known stimulator of dopamine 
receptors (Anden tl al., 1967; Ernst, 1.967) . It has also 
been shown that morphine dependent rats withdrawn for pro-
tracted periods of up to JO days show evidence of latent 
dopaminergic supersensitivity as represented by aggressive 
behavior upon aggregation (Gianutsos et al., 1974b.). 
This investigation was undertaken to develop an animal 
model of ethanol physical dependence in the rat using a 
modification of the inhalation procedure described by 
Goldstein and Pal (1971). Also, undertaken were investi-
gations of the effect of drugs in the treatment of the 
acute effects associated with ethanol withdrawal and the 
poss i ble relationship between physical dependence on etha-
nol and morphine. 
Based upon this proposal, the following predictions 
5 
which were undertaken for testing are: 
1. That continuous inhalation of ethanol vapors by rats 
along with daily injections of an alcohol dehydrogenase in-
hibitor pyrazole will result in maintainance of high blood 
ethanol levels and result in ethanol tolerance and physical 
dependence. 
2. That tolerance, either metabolic or cellular will re-
sult in alt~rations in ethanoi-induced narcosis. 
J. That physical dependence will be demonstrated by the 
presence of withdrawal signs upon cessation of chronic eth-
anol administration and that: 
a) withdrawal sign intensity could be measured by the 
use of an intensity rating scale. 
b) withdrawal signs will follow a similar time course 
of development in intensity. 
c) withdrawal signs related to ethanol withdrawal will 
be reduced by readministration of ethanol. 
d) withdrawal signs related to ethanol can be combined 
into an ethanol withdrawal syndrome measurement. 
4. · That drugs known to have cross-tolerance with ethanol 
will be effective in reducing the severity of the ethanol 
withdrawal reaction (ex. chlordiazepoxide). 
5. That administration of m'orphine will reduce the intensi-
ty of t he ethanol withdrawal syndrome. 
6. That some sign of morphine withdrawal will be seen in 
ethanol dependent and withdrawn rats. 
' ----~--- -----·-- .. ·- - . -----------~----~~---~ 
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a) aggressive behavior 
b) aggression will be enhanced by dopaminergic stimu-
lating agents (ex. apomorphine, ct-amphetamine). 
c) aggression reduced by ethanol, chlordiazepoxide 
and morphine 
It was therefore undertaken to subject animals to all 
the aforementioned conditions or treatments and to measure 
the ethanol withdrawal reaction in order to establish the 
relative value of this model of ethanol physical dependence 
in the study of alcohol addiction and to test the hypotheses 
proposed. 
' . I, 
____ __,..t.l;.:.J. ----- --·-
LITERATURE SURVEY 
ALCOHOLISM AS AN ADDICTION 
Alcoholism has been shown to be a form of addiction, as 
defined in terms of the traditional pharmacological criteria 
of tolerance and physical dependence (Isbell~ al., 1955; 
Mendelson, 1964; Victor and Adams, 1953). Recognition that 
alcoholism is an addictive disorder has proceeded slowly and 
at one time it was thought that the alcohol withdrawal syn-
drome reflected intercurrent illness, vitamin or nutrition-
al deficiencies (Victor and Adams, 1953). Now it has been 
shown that alcohol withdrawal signs and symptoms occur in 
healthy, well nourished alcoholics (Mendelson, 1964) and in 
experimental animals (Goldstein and Pal, 1971), solely as 
a fun~tion of withdrawal of alcohol. 
The crucial determinants in the development of alcohol 
addiction are unknown and the nature of the addictive pro-
~ess remains a matter of conjecture. It has generally been 
agreed that only the development of an alcohol dependent 
animal would permit the study of the addictive process at 
a behavioral, biochemical and neurophysiological level. In 
man, alcohol dependence usually evolves over many years and 
consequently, its developmental antecedents are obscured by 
time. 
7 
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ETHANOL TOLERANCE 
Data obtained over 35 years ago demonstrated that the 
severity of intoxication at similar blood alcohol levels was 
less severe in alcoholics than in abstainers (Jetter, 1938). 
The development of tolerance in alcoholics has been demon-
strated by a number of investigators (Isbell et al., 1955; 
Newman, 1941). However, the biochemical mechanisms subserv-
ing increased tolerance are unknown, but two general mech-
anism have been postulated: an enhanced rate of metabolism 
and/or an increased degree of cellular adaption to ethanol 
in the central nervous system. 
Metabolic Tolerance 
Both experimental animals (Hawkins tl al., 1966) and 
man (Mendelson tl tl•' 1966) may develop increased rates of 
ethanol metabolism following chronic ethanol administration. 
The increased ethanol metabolism in experimental animals 
has been correlated with an increase in hepatic alcohol de-
·hydrogenase activity (Hawkins et al., 1966; Mendelson et 
al., 1965). However, differences in metabolic rate alone 
do not adequately explain the high quality of tolerance 
seen in animals and man (Mendelson, 1971; Mello, 1972). 
Cellular Tolerance 
Since there is no good evidence that metabolic pro-
cesses can adequately account for the degree of tolerance 
observed in alcoholics, cellular adaption to ~thanol appears 
to be a more likely explanation for the phenomena of 
l 
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tolerance. Axelrod (1968), has reviewed several mechanisms 
which may underlie cellular adaption. Although , the models 
used were based upon possible actions of narcotics, they 
have relevance for other centrally acting drugs such as 
ethanol. Three possible factors are: 1. reduced activity 
of the drug receptor. 2. depletion of endogenous substances 
which indirectly cause or mediate drug action and J. en-
hanced metabolism and/or inactivation of the drug at its 
site of action in the central nervous system. Mendelson 
(1971), has reviewed the evidence relating to the possible 
role of ethanol as related to each possible mechanism, con-
eluding that little evidence exists supporting any of the 
proposed mechanisms of cellular tolerance discussed by 
Axelrod (1968). Furthermore,. there is little conclusive 
evidence supporting the many hypotheses (see Mechanisms of 
Tolerance and Physical Dependence) advanced to explain tol-
erance (Mendelson, 1971). A general consensus of many 
neurophysiologists and neurochemists is that ethanol acts 
on membrane structure and function, which reflects the 
lack of decisive evidence available (Mendelson, 1971). 
ETHANOL DEPENDENCE 
The occurrence of withdrawal signs upon the cessation 
of ethanol administration is evidence of physical depend-
ence. Dependence is the second major pharmacological cri-
teria of alcohol addiction. The critical determinants of 
' 'I 
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the onset of withdrawal are unclear since either a relative 
decrease in blood ethanol levels or abrupt withdrawal may 
precipitate abstinence signs. Abstinence signs have been 
observed in man (Isbell et al., 19 55; Mello and Mendelson, _ 
1970) and animals (Goldstein, 1972a.) while blood ethanol 
levels are still high. Goldstein (1972a.), found that with-
drawal signs after a single large dose of alcohol began when 
blood ethanol levels were as high as 3 mg/ml and convulsions 
were seen in some mice with blood ethanol levels greater 
than 1 mg/ml. 
Hypomagnesemia and Respiratory Alkalosis 
There has been a growing body of data on the relation-
ship between signs associated with alcohol withdrawal on 
the one hand and hypomagnesemia and respiratory alkalosis 
on the other. This area has recantly been reviewed by Victor 
(1973), who has been intricately involved in research in this 
area. Vi ctor (1973), noted that three separate studies, of 
which two were clinical and one experimental, involving a 
total of 58 patients, the only two consistent chemical ab-
normalities during withdrawal were hypomagnesemia and res-
piratory alkalosis. Furthermore, he observed that the 
severity of these chemical abnormalities were related and 
followed a similar time course as the seizures associated 
with the wi t hdrawal. As to the mechanism involved Victor 
(1973), suggested that it may involve rebound suppression 
of the resp i ratory centers during alcohol intoxication 
with respiratory alkalosis and magnesium shift in response 
---~ --·----
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to the alkalosis. He also suggested that a concomitant 
mechanism might be cerebral hypoxia secondary to the respir-
a:'t'ory alkalosis. 
Sleep Disturbances 
Considerable research in the past decade has been di-
rected to the study of the relationship between sleep dis-
turbances and the phenomenology of the acute alcohol with-
drawal syndrome. Clinical investigations have demonstrated 
consistently that patients admitted in acute alcohol with-
drawal states who were hallucinating were likely, if they 
could sleep, to have elevation in Stage I REM (rapid eye 
movement), that part of sleep associated with vivid dream-
ing (Gross et al., 1966; Gross and Goodenough, 1968; Green~ 
berg and Pearlman, 1967; Johnson~ al., 1970). Levels as 
high as 100% Stage I REM (normally 20%) were observed in 
hallucinating patients in full-blown delirium tremens 
(Gross et al ., 1966; Johnson~ al., 1970). Thus, in al-
coholics there appears to be a relationship between REM 
and the hallucinations of withdrawal . Alcohol also reduces 
REM in normals (Yules~ al., 1966) and in chronic alcohol-
ics (G~oss and Goodenough, 1968). This suggests that an im-
portant mechanism involved in the hallucinogenesis during 
acute alcohol withdrawal may be rebound of REM and its as-
sociated dream activity. If REM rebound were great enough 
it might break through into the waking state as hallucina-
tions (Fisher and Dement, 1963) as was once observed (Gross 
et al., 1966). There is also a marked reduction in delta 
12 
sleep which may be an important condition permitting very 
high levels of REM (Johnson et al., 1970). Johnson et al. 
(1970), suggested that the sleep changes may result from 
the effect of ethanol on brain biogenic amines. This posi-
tion is shared by Williams and Salamy (1972), Lester et al., 
(1973) and Kissin ~al. (1973). 
Denervation Supersensitivity 
Jaffe and Sharpless (1968), pointed out that many with-
drawal phenomena involve an exaggeration of behavior that 
is ordinarily suppressed by the agent which induces depend-
ence. For example, morphine ingestion in man is associated 
with myosis while mydriasis is observed during morphine with-
drawal . In addition to the concept of rebound hyperexcita-
bility exists during the time the agent is ingested (Jaffe 
and Sharpless, 1968). 
The phenomena of denervation supersensitivity has been 
used as a model to explain central nervous system (CNS) 
seizure activity in severe abstinence syndromes . It has 
been suggested that chronic CNS depression by barbiturates, 
morphine, alcohol, etc., is tantamount to " disuse" (analo-
gous to peripheral nervous system (PNS) denervation. Upon 
removal of the drug, there is a consequent rebound hyper-
excitability of the functional systems depressed (Jaffe and 
Sharpless, 1965). Therefore, drugs that elevate thresholds 
for chemically induced seizures would be expected to exhibit 
lowered seizure thresholds during withdrawal. The formula-
; 'J' 
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tion of "disuse supersensitivity" is supported by the find-
ing that whi~e barbiturates are known to increase the thresh-
hold for pentylenetetrazol (PTZ)-induced seizures, barbitur-
·,: 
ate withdrawal in the addicted cat is associated with a de-
creased threshold for PTZ-induced seizures (Jaffe and 
Sharpless, 1965). Jaffe and Sharpless (1965), concluded 
that the lowered threshold for seizures was consistent with 
a "disuse supersensitivity" model of physical dependence 
and that the time course for the development of physical 
dependence is similar to that of denervation supersensitivity 
in the PNS as observed by Fleming and Trendelenburg (1961). 
MECHANISMS OF TOLERANCE AND PHYSICAL DEPENDENCE 
Tolerance and physical dependence have been discussed 
as ~eparate entities although both are essential criteria 
for addiction. Tolerance and physical dependence may re-
present phenomena subserved by a common mechanism or may 
represent different biochemical and physiological pro-
cesses. It is well known that certain centra~ly acting 
drugs produce tolerance but no physical dependence. For 
example, amphetamine produces no clear-cut dependence, 
while t olerance to increasing doses is common (Jaffe, 1970). 
Way et al. (1969), has presented strong evidence that a 
common mechani sm underlies the development of tolerance 
and physical dependence to morphine in mice. However, prior 
to similar experiments being done in alcohol addiction a 
satisfa ctory a nimal model of ethanol physical dependence 
is needed ( Mend elson, 1971). 
.:..---·---
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Enzyme Expansion Theory 
Goldstein and Goldstein (1967), have developed an en-
zyme expansion theory of' drug tolerance and physical de-
pendence. This theory consists of' tolerance and physical 
dependence as a unitary mechanism based upon represssion and 
derepression of' enzyme synthesis. Substance C in Figure 1 
is considered excitatory at some regional or cellular level 
· in the central nervous system. Substance C is synthesized 
via precursor B catalyzed by enzyme E. Levels of' C are 
enzyme 
degradation 
precursors B 
Figure 1 
enzyme synthesis 
f -!- -repression 
I 
E 
I 
I 
------c 
I 
inhibition 
I 
I 
x 
utilization or 
metabolism 
maintained via feedback inhibition or repression of' synthe-
sis of' enzyme E. Drugs such as ethanol are proposed to in-
hibit enzyme E thereby reducing synthesis of' substance C. 
The reduced levels of' C result in increased levels of' syn-
thesis of' E restoring normal levels of' excitatory substance 
C . . At t hi s time both high levels of' drug (ethanol) and en-
zyme exists (tolerance) but with normal CNS function. With-
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drawal of ethanol results in release of inhibition of en-
zyme E which results in increased levels of C and overex-
citation and the withdrawal phenomena (physical dependence). 
Increased Receptor Sites 
Collier (1965), proposed a theory based upon the hypo-
thesis that drugs with addictive potency induce an increase 
in receptor sites. This theory proposes that active recep-
tor sites exist in cells which bind with the drug (possibly 
receptors for endogenous substances ex. neuroamines). When 
the drug is administered in increasing dosage, new recep-
tors are made to replace those bound by the drug. Thus as 
more receptors develop more drug is needed to bind them, 
hence tolerance. Removal of the drug results in availability 
of an excess of receptors which are active and results in 
excitation and withdrawal signs. 
Acetaldehyde, Alcohol and Biogenic Amines 
Th e r e have been a number of suggestions that the phe-
nomena of tolerance and physical dependence on alcohol may 
not be directly related to the action of ethanol on neural 
tissue, but rather related to a crucial metabolite. Truitt 
and Walsh (1971) have stressed the importance of the ethanol 
metabolite acetaldehyde in the actions of ethanol. Further-
more, acetaldehy de may have a direct role in the development 
of tolerance a nd phy sical dependence upon ethanol (Ortiz 
et al. , 1974). 
Al though some authors believe that ethanol's effect on 
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nerve membranes is primarily involved in the production of 
physical dependence upon ethanol either directly (Wallgren, 
1973) or indirectly via binding of biogenic amine aldehydes 
(Tabakoff £.i al., 1973), synaptic events involving catecho-
lamines are not dismissed. 
Chronic ethanol administration is known to cause sus-
tained release of norepinephrine in the brain (Hunt and 
Majchrowicz, 1974), which has lead to investigation and 
speculation that this release of norepinephrine is directly 
responsible for at least some of the characteristics of 
ethanol tolerance and physical dependence (Reis, 1973; 
French et al., 1974). Davis et al. (1967b.), found that 
ethanol and acetaldehyde cause release of norepinephrine 
and alter its metabolism from the normal oxidative pathway 
towards a reductive one of a glycol excretion product 
(methoxyhydroxyphenylglycol, MHPG) a similar shift involv-
ing serotonin was also seen (Davis et al., 1967a.). How-
ever, although the metabolism of dopamine via the oxidative 
route was reduced no increase in the reductive pathway was 
seen (Davis, 1971). The shift in catecholamine metabolism 
is believed to be due to the inhibition of aldehyde re-
ductase in the brain by acetaldehyde formed from the metab-
olism of ethanol via alcohol dehydrogenase, catalase and 
the microsomal ethanol oxidizing system proposed by Lieber 
and DeCarli (1968). The feasibility of a role for ace-
taldehyde in alcoholism has recently been given support 
.. .t..~ .1'..J 
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from Kersten et al. (1975), who found that the blood levels 
of acetaldehyde were elevated in alcoholics compared to 
normals after equal doses of ethanol and at similar blood 
ethanol levels. Hasumura et al. (1975), presented evidence 
that the elevation in acetaldehyde levels in alcoholics may 
result from the chronic intake of ethanol, since it was 
found that in rats chronic administration of ethanol1.n-
hibited acetaldehyde oxidation by liver mitochondria. 
Although the shift in catecholamine metabolism, pre-
viously cited, may not itself be important, the fact that 
dopamine metabolism does not increase through the reductive 
pathway focused attention on this neuroamine. Walsh et al. 
--
(1970), found that under conditions which limited the meta-
bolism of the dopamine derived aldehyde (J,4-dihydroxyphenyl-
acetaldehyde) an alkaloid metabolite, tetrahydropapaveroline 
(THP) was formed from the condensation of dopamine with its 
aldehyde metabolite . Davis~ al . (1970), found that alco-
hol or acetaldehyde considerably augmented the formation of 
THP in vitro. It is known that in plants THP is the requi-
site intermediate in the biosynthesis of complex alkaloids 
including morphine, aporphine and papaverine alkaloids 
(Battersby, 1961; Spenser, 1966). Davis~ al, (1970), pro-
posed that the formation of such alkaloids may represent 
the mechanism for the addiction liability of ethanol (see 
Figure 2 for proposed mechanism). A recent review of the 
background for this hypothesis has recently been published 
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(Walsh, 1973). This hypothesis has been criticized by 
Seevers (1970) and by Goldstein and Judson (1971), based up- . 
on the failure of naloxone to induce a typical narcotic 
withdrawal sign (jumping) in ethanol dependent mice. 
There has also been presented in the literature, al-
most simultaneously to the above studies, studies which have 
shown that acetaldehyde or formaldehyde will condense, via 
the simple Pictet-Spengler reaction, with dopamine or no-
repinephrine to form tetrahydroisoquinoline alkaloids (THis) 
(Cohen, 1971; Yamanaka et al., 1970). Figure J shows the 
possible alkaloids. 
Figure J 
CATECHOLAMINE R1 -HC=0 
ALDEHYDE 
> 
Formation of 1,2,J,4-tetrahydroisoquinoline (TIQ) 
alkaloids from catecholamines by condensation with 
aldehydes. The aldehydes are formaldehyde (R1 = H) 
and acetaldehyde (R1=CH3 ). The catecholamines are dopamine (R2=R1=R4=H),norepinephrine (R2=R3=H; R4= 
OH) and epinephrine (R2=CH; RJ=H; R4=0H). 
Cohen and his co-workers after much experimentation proposed 
that these condensation products act as false adrenergic 
transmitters and meet the essential requirements of synthe-
sis, uptake, storage and release by the adrenal and peripher-
al adrenergic nerves (Cohen, 197Ja.; 197Jb.). Recent work 
---4~~.;.;. --- ---~--·--
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has shown that these THis are differentially secreted from 
the adrenals, such that in the presence of Ca++ both cate-
cholamines and THis are released, however when Ca++ is ab-
sent only the catecholamines are released (Rahwan et~., 
1974). 
These hypotheses concerning acetaldehyde are very pro-
vocative and have created much furor in the past few years. 
Similarities between the actions of morphine and ethanol 
are not unknown in the literature. Ross et al. (1974), has 
shown that both morphine and ethanol as well as salsolinol 
(a THI) and reserpine deplete regional brain Ca++, however, 
only the effects of morphine, ethanol and salsolinol were 
antagonized by naloxone a narcotic antagonist. Swartz et 
al. (1974), showed that acute doses of ethanol inhibit the 
uptake and binding of Ca++ by cardiac microsomes. There-
fore, if one examines the available data: 1. ethanol and 
salsolinol deplete regional brain calcium, possibly via in-
hibition of uptake and binding 2. the depletion of calcium 
would favor release of catecholamines (NE) over THis J. the 
release of NE after ethanol administration is already well 
known as is the diversion of its metabolism in the presence 
of ethanol or acetaldehyde. Furthermore, it has been shown 
that barbiturates also induce a similar shift in norepine-
phrine metabolism as does ethanol or acetaldehyde (Davis 
~al., 1974) presumed to be due to inhibition of aldehyde 
reductase as shown by Tabakoff and Erwin (1970). 
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Thus, signs which are used to categorize the withdrawal 
syndrome consist of a mixture of central, peripheral and de-
rivative metabolic effects which are not easily explained 
by enzyme derepression, receptor induction or neuroamine al-
teration theories. At the present time it appears as if 
tolerance and physical dependence on alcohol have multiple 
determinants whose mechanisms relate to complex interactions 
of neural, endocrine and metabolic functions. 
ASSESSMENT OF ETHANOL TOLERANCE ..:.. 
Kalant et al. (1971), has reviewed the many techniques 
for assessing tolerance to ethanol. Various investigators 
have used electroshock seizure thresholds (Allan and Swinyard, 
1949) and motor performance (Gibbins~ al., 1968; Moskowitz 
and Wapner, 1964; LaBlanc et al., 1969). In most instances 
changes in metabolic distribution cannot explain ;the degree 
of tolerance observed (LaBlanc et al., 1969; Mendelson, 
1971). 
Increases in the rate of ethanol elimination have been 
shown in man (Mendelson et al., 1966) and animals (Gibbin~ 
et al., 1966). Animals made physically dependent on ethanol 
have also been shown to have increased rates of ethanol 
elimination (Mello, 1973). However, the behavioral methods 
cited above have been carried out in non-dependent animals, 
possibly due to the interference of the withdrawal reac-
tion with the performance of such tasks as rotor rod per-
-· ......,..;.J::.i 
f'ormance. Tolerance to alcohol in non-dependent mice did 
not return to normal f'or at least 14 days and not f'or 3-4 
weeks when tolerance was at its maximum f'ollowing ethanol 
treatments (LaBlanc 2.E_ al. 1969). 
ASSESSMENT OF ETHANOL WITHDRAWAL 
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For many years, investigators have concentrated upon 
devising techniques f'or inducing preference f'or alcohol in 
animals. There has also been an unfortunate tendency to 
equate a transitory alcohol pref'erence with addiction even 
though no withdrawal signs and symptoms occurred upon cessa-
tion of' chr9nic drinking. Removal of' the f'actors which ac-
celerated alcohol pref'erence (ex. noxious stimuli), is 
usually accompanied by a decreased alcohol intake. Reviews 
of' this area have been published (Lester, 1966; Mello, 1968; 
Myers and Veale, 1972; Woods and Winger, 1971). 
Recently, several groups have produced physical de-
pendence upon alcohol in animals using oral, intragastric, 
intravenous and inhalation routes of' administration. Al-
though, there is some interspecies variability in the types 
of' withdrawal signs, there has been reasonable agreement 
f'rom diff'erent laboratories (Mello, 1973). Majchrowicz 
(1973) and Roach 2.E_ al . (1973), have outlined most of' the 
ethanol withdrawal signs in rats. Withdrawal after several 
days of' 3-5 f'ractional daily doses of' ethanol 12-15 g/kg/day 
in rats resulted in withdrawal signs of' "squealing, hyper-
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activity, ventromedialdistal forepaw flexion , spascity, tre-
mors, teeth chattering, wet shakes, induced and spontaneous 
convulsions" (Majchrowicz, 1973). Withdrawal after 7 days 
of inhalation of ethanol without pyrazole resulted in tremors , 
forward tail-arching, hypersensitivity to sound and touch, 
abnormal postures and convulsions (Roach et al., 1973). How-
ever, neither investigators attempted to do more than group 
the withdrawn rats based upon an overall subjective inter-
pretation of withdrawal severity, rather than by systemati-
cally assessing each sign. 
Although, comprehensive behavioral rating scales have 
been developed for withdrawal signs in mice (Irwin, 1968; 
Goldstein, 1972a.; Freund, 1969) few have been developed for 
other species and none for the rat (Mello, 1973). Since , 
the grossly observable withdrawal signs presumably repre-
sent central nervous system hyperexcitability directly by 
examining the seizure threshold to electro-convulsive shock 
(McQuarrie and Fingl, 1958)' audiogenic stimuli and convul-
sive drugs (Ratcliffe, 1972) and the startle response 
(Gibbins et al., 1971). 
Oral and Intragastric Administration 
Falk (1972), reported successful application of a be-
haviora l technique, schedule-induced polydipsia, in pro-
ducing ethanol physical dependence in the rat. The poly-
dipsia phenomena was first reported by Falk (1961). Substi-
tution of a 5 or 6% ethanol solution for water resulted in 
daily intak.es of between 11 and 15 g/kg with blood levels v 
I 
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maintained above 1 mg/ml. Physical dependence resulted af-
ter 3 months of exposure to the polydipsia technique. 
Freund (1969), feed liquid diets containing 35% of the ca-
loric intake as ethanol to mice on a food-restricted diet. 
Although, this procedure induced gross intoxication and 
physical ' dependence in four 'days, the severe weight reduc-
tion, to 65% of their free-feeding weight, prior to ethanol 
administration introduces some serious inadequacies into 
this model (Ogata et al., 1972). It has been shown both in 
animals and man that the rate of ethanol metabolism is re-
duced by as much as 50% in fasted organisms (Forsander et 
al., 1965; Mendelson, 1970; Owens and Marshall, 1950; Smith 
and Newman, 1959). The Freund method has also been applied 
to rats (Branchey et al., 1971). 
' --
Gastric intubations of 3-5 fractional daily intubatiohs 
of 12-15 g/kg/day of ethanol in rats has produced physical 
dependence ih approximately 7 days (Majchrowicz, 1973). 
Several unsucces sful studies using the polydipsia tech-
nique with rhesus monkeys to induce physical dependence did 
yield the important result that maintenance of consistently 
high blood ethanol levels on successive days is important 
for induction of physical dependence on ethanol (Mello and 
Mendelson, 197la.; 197lb.). 
Us e of on e to seven-month-old chimpanzees (Pan troglo-
dytes) given liquid diets with 45% of the calories as eth-
ano l at s t andard fe e ding times has resulted in physical 
- I .,,:__..., • ..I..--.-. ----
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dependence (Pieper et~., 1972). The chimpanzees main-
tained normal weight gain, consumed ethanol at 2-8 g/kg/day 
with blood levels ranging between 0.5-J.O mg/ml for 6-10 
weeks ana displayed hyperreflexia, irritability, spastic 
rigidity and tonic-clonic convulsion upon abrupt withdrawal 
of ethanol (Pieper~ al., 1972). This liquid diet .proce-
dure was extended to adult rhesus monkeys with comparable 
results including significant increases in the rate of eth-
anol metabolism (Pieper and Skeen, 1972). 
Forced alcohol administration procedures have proved 
to be consistently effective in producing alcohol depend-
ence in monkeys (Ellis and Pick, 1969; 1970b.; 1971) and in 
dogs (Ellis and Pick, 1970a.; E~sig and Lam, 1968; 1971). 
Ellis and Pick (1969), were the first to report that naso-
gastri c intubation of alcohol (25%) in 2-J daily doses of 
4-8 g/kg for 10-18 days produced physical dependence in 
rhesus monkeys with increases in ethanol metabolism. Essig 
and La m (1968), were the first to report ethanol physical 
dependence in dogs following prolonged ad~inistration via 
surgically implanted gastric cannula. Upon withdrawal the 
authors described states of apparent hallucinations and 
disrupted sleep as well as tremulousness .and convulsions 
(Essig and Lam, 1968; 1971) . 
Intravenous Administration 
Yana g ita et al. (1965), were the first to report etha-
nol physical d e pend ence in monkeys using a paradigm in 
11 
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which a monkey could lever press to self'-administer ethanol. 
Their original work was conf'irmed and extended (Deneau et 
al., 1969; Winger et al., 1970; Woods and Winger, 1971; 
Woods~ al., 1971). Consistent delivery of' 6-8 g/kg/day 
f'or 10 weeks was suf'f'icient to produce withdrawal signs up-
on withdrawal of' ethanol injections (Deneau ~al., 1969). 
There are striking similarities between the patterns of in-
travenous self'-administration of' ethanol by the rhesus mon-
key and spontaneous drinking patterns in human alcoholics 
(Deneau et al., 1969; Mello and Mendelson, 1972; Nathan~ 
al., 1970; Nathan et al., 1971; Woods et~., 1971). Human 
alcoholics, given an operant task, f'requently alternate 
drinking episode of' J-6 days with relatively abstinent work 
periods associated with partial withdrawal signs lasting 
2-J days (Mello a n d Mendelson, 1972; Nathan et al. , 1970; 
Nathan~ al., 1971). Alcohol self'-administration in mon-
keys is also punctuated by periods or spontaneous absti-
nen ce and partial withdrawal signs (Deneau et ·al., 1969; 
Woods et al., 1971). This raises some basic questions con-
cerning the ambiguous relationship between physical depend-
ence and subsequent drug self-administration. It is usually 
assumed that once an addictive drug-taking pattern is estab-
lished, the avoidance of withdrawal signs and symptoms is 
a critical f'actor in maintenance of drug use. However, 
avoidance of withdrawal per se does not appear to be the 
only factor involved in the maintenance of alcohol self-
admin,istra t ion. 
. - _________ ,......;....~.t:.a ,..: ( 
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Inhalation Administration 
Goldstein and Pal, (1971), reported alcohol dependence 
·in mice exposed to inhalation of ethanol vapors and daily 
injections of pyrazole (68 mg/kg) for 3-4 days. Chamber 
ethanol concentrations were between 10-16 mg/liter which 
resulted in blood levels of approximately 1.8 mg/ml (Gold-
stein and Pal, 1971). Upon removal from inhalation of eth-
anol withdrawal signs of tremors, convuisions to handling, 
tail-lifts, startle reactions and spontaneous seizures were 
seen with peak intensity occurring 10-12 hours after with-
drawal (Goldstein and Pal, 1971; Goldstein, 1972b.). This 
model has the advantage of producing large numbers or phy-
sically dependent animals in a relatively short time. 
Goldstein has used this model to study the mlationship be-
tween alcohol dose and the intensity of withdrawal signs, 
effects of drugs which modify neurotransmission and the 
effect of other drug on the withdrawal reaction (ex. chlor-
diazepoxide) (Goldstein, 1972a.; 1972b.; 1973). Roach et 
al. (1973), has reported production of physical dependence 
in rats by inhalation of ethanol without the use of pyra-
zole after 7 days of inhalation at concentrations of 15-30 
mg/liter. Upon withdrawal the rats were subdivided into 
3 groups, slightly dependent, moderateiy dependent and 
severely dependent based upon an overall subjective evalu-
ation of the withdrawal signs. Blood levels varied widely 
with means of from 0.8 mg/ml to 3 mg/ml of ethanol. 
. .. .--
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Alcohol and Pyrazole 
Goldstein (1972a.), found that the use of pyrazole was 
necessary, since without it blood ethanol levels fluctuated 
drastically resulting in a high mortality rate during etha-
nol inhalation. 
Pyrazole inhibits the metabolism of ethanol both in 
vitro and in vivo. Theorell et al. (1969) , reported that 
pyrazole inhibited alcohol dehydrogenase by formation of a 
ternary complex with ADH and nicotinamide adenine dinucleo-
tide (NAD). Lester£! al. (1968) and Goldberg and Rydberg 
(1969), showed that pyrazole inhibited ethanol metabolism 
in rats and that the minimal lethal dose was approximately 
18 mmole/kg (1200 mg/kg). Lester and Benson (1970), found 
that the metabolism of other alcohols including ethanol are 
inhibited by pyrazole as well as some oximes and amides. 
Rydberg et al. (1972), has studied the kinetics of pyrazole 
and reported that not only does pyrazole inhibit ethanol 
metabolism, but that administration of ethanol increased 
the half-life of pyrazole from 13 to 21 hours. Rydberg et 
al. (1972), suggested that ethanol might inhibit a micro-
somal m~chanism for pyrazoles elimination (Rubin et al., 
1971). Bustos£! al. (1970) and Morgan and DiLuzio (1970) 
have dealt with the induction of fatty-livers in animals 
treated with pyrazole and ethanol. 
Pyrazole is known to have hepatotoxic effects (Lelbach, 
1969; Lieber et al., 1970) and some synergistic action with 
I 
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ethanol upon the central nervous system (Goldberg et al., 
1972). However, overall pyrazole is well tolerated in rats 
at doses which are highly effective at reducing ethanol 
metabolism (Lester and Benson, 1970) and in most cases tox-
ic effects are not seen unti~ the dose of pyrazole is quite 
high, usually greater than several hundred milligrams per 
kilogram of body weight. 
TREATMENT OF ETHANOL WITHDRAWAL 
There is a vast literature on the use of a wide variety 
of drugs in the specific rather than the supportive treat-
ment of the alcohol withdrawal syndrome, The rationale for 
the usefulness of these agents has followed two basic di-
rections. One direction has been to find effective central 
nervous system depressants which, by their cross-tolerance 
to alcohol, would theoretically be effective in the treat-
ment of acute withdrawal. This has been emphasized by 
Isbell et al. (1955). The other direction has been the 
use of major and minor tranquilizers to calm and sedate 
patients. The former presumably attacks the underlying 
mechan i sm, the latter symptoms of anxiety, agitation and 
hallucinations. 
Specifi c Treatment of Acute Alcohol Withdrawal 
The data suggest that specific treatment applies to 
the impendi n g delirium t r emens than to delirium tremens 
(Gross tl al.', 1974). Cross-tolerant drugs were signifi-
--..-1...l.l;.J. ---· ........ __ ----
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cantly more effective in preventing delirium tremens and in 
reducing seizures than non-cross-tolerant drugs (Golbert et 
al., 1967; Kaim et al., 1969). · In the case of delirium 
tremens, the characteristic of cross-tolerance may not be 
as important and it is the opinion of many cl~nicians that 
the difference between the clinical efficacy of cross-toler-
ant and non-cross-tolerant drugs may be less critical than 
the experience of the clinician in detecting complications 
and correcting such problems as electrolyte imbalance (Gross 
et al., 1974; Victor, 1966). However, use of paraldehyde 
is still extensive and is vigorously supported for treatment 
of delirium tremens (Victor, 1966) . Although a recent su~­
vey of physicians by Favazza and Martin (1974), found that 
chlordiazepoxide was favored by almost 2 to 1 as the drug 
of choice in the treatment of delirium tremens, other ex-
perimental work ers have found no difference between chlor-
diazepoxide and paraldehyde. This is of interest, since 
the major metabolite of paraldehyde is acetaldehyde. 
Ethanol in the Treatment of Alcohol Withdrawal 
Withdrawal reactions follow when chronic administration 
of a dependence produ cing drug stops, and the signs should 
therefore be relieved by reinstating the same drug or its 
pharmacological equivalent. Isbell~ al. (1955), pointed 
out that ethanol should relieve alcohol abstinence, but 
st r essed the limitations of such therapy in practice (rapid 
metabolism, low margin of safety). According to Golbert 
1.4. ...... t .. ·- -----~~~---~--
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et al. (1967), alcohol treatment does not always prevent the 
appearance of delirium tremens in man. Goldstein (1972b.) 
in mice and Ellis and Pick (1970b.) in monkeys, showed that 
ethanol does act as expected in reducing withdrawal severi-
ty. Goldstein (1972b.), has also shown that paraldehyde, 
meprobamate and barbiturates, which have similar pharmaco-
logical properties to ethanol, are also effective · in treat-
ing wi thdra~l in mice. 
Comparison of Major and Minor Tranguilizers in Acute Alco-
hol Withdrawal 
A comparative study of chlordiazepoxide, paraldehyde 
and haloperidol found that in the treatment OI uncomplicated 
acuLe alcohol withdrawal in man the rate of improvement was 
signiricantly greater with chlordiazepoxide over the long 
run (fourth day of observation), however, during the first 
48 hours all drugs worked effectively with no significant 
difference between them (Gross et al., 1974). 
Other major tranquilizers have been tested in the 
treatment of alcohol withdrawal. The use of cnlorpromazine 
· or promazine were compared wiLh paraldehyde and/or chlor-
diazepoxide in the treatment of delirium tremens (Kaim et 
al., 1969; Thomas and Freedman, 1964). In all cases chlor-
promazine and promazine were markedly inferior. While proma-
zine was no different than chlordiazepoxide in several symp-
toms other than delirium tremens, promazine failed to suppress 
convulsions (Chambers and Schultz, 1965). Thomas and 
J2 
Freedman (1964) and Golbert et al. (1967) reported an alarm-
ing increase in mortality after promazine compared to paral-
dehyde or chlordiazepoxide. These results are in agreement 
with Goldstein (1972b.), who found that administration of 
promazine or chlorpromazine increased the severity of the 
withdrawal in ethanol dependent and withdrawn mice. Al-
though Goldstein (1972b.), found chlordiazepoxide, diazepam 
and long-acting barbiturates highly effective in reducing 
withdrawal signs in mice, it was also reported that a sig-
nificiant increase in mortality in mice treated with these 
long-acting drugs. The cause for the increased mortality 
was unknown and it was suggested that the disorder may 
have been one which is routinely corrected in a clinical 
situation, such as electrolyte or fluid imbalance. However, 
more seriously they may add to the brain damage caused by 
several days of intoxication and due to their cross-tolerant 
nature be equivalent to further days of intoxication and 
subsequently increase the withdrawal severity (Goldstein, 
1972b.). 
It appears that the clinical use of drugs is a very 
complex problem. Although, ,paraldehyde and chlordiazepox-
ide appe a r to emerge as consistently effective treatments, 
clinica l management appears to have at least as much im-
portance (Gross et al., 1974). 
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WITHDRAWAL AGGRESSION 
Rats made physically dependent upon morphine display in-
tense aggression during withdrawal without any other stimu-
lation (Puri and Lal, 1973). This spontaneous aggression 
is enhanced by direct and indirect acting dopamine receptor 
stimulants, such as apomorphine and amphetamine and is blocked 
by the narcotic methadone or the dopamine receptor blocking 
neuroleptic haloperidol (Puri and Lal, 197J). It has been 
proposed that morphine withdrawal aggression indicates the 
presence of dopamine receptor supersensitivity (Puri and 
Lal, 197J). Apomorphine is known to be a direct dopamine 
receptor stimulator (Anden ~al., 1967; Ernst, 1967) and 
capable of inducing aggression itself, but at doses several 
fold higher than doses which intensify morphine withdrawal 
a ggression (Gianutsos, 1974). Dopamine receptor super-
sensitivity appears to be latent for protracted periods of 
up to at least JO days after withdrawal of morphine, demon-
strated by intense aggression in morphine dependent and 
withdrawn rats after JO days (Gianutsos etal., 1974b). The 
involvement of dopamine receptor supersensitivity in the 
production of aggression has been further supported by evi-
dence that chronic blockade of dopamine receptors by the 
neuroleptic haloperidol results in increased sensitivity to 
apomorphine-induced aggression (Gianutsos et al., 1974a.). 
It has been proposed that acute adminstration of morphine 
can result in blockade of dopamine receptors similar to 
haloperidol, but less potent (Puri~ al., 197J). 
Animals: 
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Long-Evans strain, male hooded rats weighing 150-400 
grams (Charles River Breeding Laboratory, Wilmington, Mass.) 
were used in this study. They were housed in animal quar-
ters maintained at 21-2J°C with room lights alternated on 
a 12-hour light-dark cycle. The rats were housed in groups 
of 15 or less with food and water available ad libitum at 
all times unless specified otherwise. 
Materials: 
Analytical grade chemicals or equivalent were used 
throughout the study. Ethanol (95%) used for production 
of ethanol vapors and animal dosing was obtained from U.S. 
Industrial Chemical Co., New York, N.Y. Sodium pyrophos-
phate, sodium carbonate and giycine used for the blood al-
cohol assay were obtained from Mallinckrodt Chemical Works, 
St. Louis, Mo. Apomorphine-hydrochloride was obtained 
f~om Mallinckrodt Chemic a l Works. Alcohol dehyarogenase-
(Alcohol: NAD oxidoreductase; E.C. No. 1.1.1.1) from yeast; 
crystallized and lyophilized powder,~ -diphosphopyridine 
nucleotide(~ -DPN;~ -NAD)- yeast and aminooxy acetic acid 
(hemi-hydrochloride) were obtained from Sigma Chemical Co., 
St. Louis, Mo. Librium (Chlordiazepoxide-HCl Lot #670110) 
was obtained from Hoffman-La Roche, Inc., Nutlet, N.J.~ 
Morphine sulfate (U.S.P. Crystalline) was obtained from 
Merck Chemical Division, Rahway, N.J. Pyrazole (99%) was 
obtained from Aldr ich Chemical Co., Inc., Milwaukee, Wis. 
I .i. ;~_,';, 
35 
Ethanol Vapor Chamber: 
The ethanol vapor chamber consisted of a flat bottom, 
cylindrical glass bell jar placed horizontally on a wooden 
platform. It contained a perforated metal grid floor, drink-
ing water bottle and food pellets. The open end of the jar 
was closed by a wooden frame sealed by a cork liner and 
fitted with a rubber stopper (2" diameter) having four holes . 
The rubber stopper was fitted with two inlets (one for air 
and one for ethanol vapors) an outlet and a thermometer. 
Compressed air (20 psi) was directed via a Y-tube to two 
flow-meters. The flow-meter regulating air flow had a range 
of 0-11. 5 liters/min; the flow·-meter regulating ethanol va-
pors a range of 0-0.95 liters/min (Fisher and Porter c~ ., 
Warminster, Pa.). The air flow-meter was connected directly 
to the ethanol vapor chamber, while the ethanol flow~meter 
was connected to a 500 cc gas-washing bottle (Thomas ~o., 
Philadelphia, Pa.) containing 95% ethanol. The ethanol 
vapors produced flowed into the ethanol vapor chamber where 
it was mixed with the air flow. 
Determination of Ethanol-Vapor Concentration: 
The concentration of ethanol in the inhalation chamber 
was determined using a Packard 810 Gas Chromatograph (Packard 
Instrument Co., Inc., Downers Grove, Ill . ). Column packing 
was Carbosieve-B GSC, mesh 45/65 (Superlco, Inc., Belle-
fonte, Pa.). The inlet temperature was 200°C, column 190°C 
and detector 200°C. The nitrogen carrier flow was 90 cc/ 
minute. 
' ~ .. lo.... ..... ------- .. -
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Standard analysis was done by injecting 1 ul of abso-
lute ethanol. Air flow to the chamber was constant at 5.0 
liters/min and ethanol vapor flow-rates were set from 0.2-
0.9 liters/min. The chamber was allowed to equilibrate for 
JO minutes prior to sampling~ Unpublished results from our 
lab have shown that chamber ethanol concentrations are 
stable 15 minutes after ethanol vapor flow-rates are changed 
(Drawbaugh~ al., 1973). Samples of chamber air (1 ml) 
were withdrawn from the outlet tube using a Hamilton air-
tight syringe (Hamilton Co., Inc., Calif.) and injected on 
to the column. 
Ethanol comes off Carbosieve-B as a distinct, but some~ 
what broad peak. Therefore, analysis was based upon the 
weight of each curve. The curve was cut out and weighted 
to the nearest milligram using a Mettler H 20 balance 
(Arthur Scientific Co., Philadelphia, Pa.). Chamber ethanol 
concentrations were determined as follows: 
(lml) 
(lul) 
sample weight x attenuation 
standard weight x attenuation 
mg/liter/ethanol 
x 1000 x 0.8 mg/ul = 
Figure 4 demonstrates the relationship between ethanol vapor 
flow-rate and chamber ethanol concentrations. 
,~ ...... ~- .... - .. 
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Figure 4. REIATIONSHIP BE'IWEEN ETHANOL VAPOR FI.CM-RATE AND CHAMBER 
ETHANOL VAPOR CDNCENTRATION. Each :i;:oint represents the 
mean + S.E. of 3 samples of va:i;:or taken from the outlet 
of the ethanol va:i;:or chamber at ethanol flow-rates of 
0.2, 0.4, 0.5, 0.6, 0.7 and 0.8. liters/min. Air flCM-
rate was constant at 5 . 0 liters/min. 
·' 
' I . 
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Determination of Blood Ethanol Levels: 
The assay procedure was that of Jones et al. (1970). 
Rats were removed from the inhalation chamber and anesthes-
tized with ether and a small blood sample collected from 
the tail vein in a heparinized vial. A sample of 100 ul 
was . deproteinized with perchloric acid (4.9 ml, J.4%). The 
supernatant obtained after centrifugation at JOOO rpm for 
10 minutes was used directly for analysis. The supernatant 
(100 ul) was added to 2.6 ml of ice-cooled reagent in capped 
vials containing per liter O.OJ mole of sodium pyrophosphate, 
0.04 mole glycine, 0.11 mole sodium carbonate, O.OJ mole 
aminooxyacetic acid, 0.0017 mole nicotinamide adeni~e di-
nucleotide (NAD+; alcohol free grade) and 25 units of crys-
1 talline yeast alcohol dehydrogenase per assay (pH 8.8-9.2) 
The reaction mixture was then incubated at J0°C in a con-
stant temperature bath wi~h shaking for 10 minutes. The re-
action mixture was then allowed to sit at room temperature 
for 15 minutes at which time the absorption was measured 
at J40 mu. The optical density, after subtraction of a 
non-ethanol blank value, was proportional to the concentra-
tion of ethyl alcohol in the blood. The standard analysis 
was made by addition of 100 ul of ethanol standard solu-
tion containing 0.25, 0.5, 1.0 and 2.0. mg/ml ethanol in 
1
Preparation of 50 ml of reagent was done by adding 0.699 
g sodium pyrophosphate, 0.1500 g giycine, 0.682 g sodium 
carbona t e, 0.164 g aminooxyacetic acid, 0.064 g NAD+ and 
1.09 mg (25 uni t s) of alcohol dehydrogenase to 50 ml of 
dis ti lled wat er . . 
; . 
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distilled water. The standard solutions of ethanol were 
prepared as follows: 1 ml absolute ethanol = o.8 g ethanol, 
.2.5 ml/absolute ethanol = 2.0 g ethanol. Therefore, 2.5 ml/ 
absolute ethanol q.s. to 1000 ml contains 2.0 mg/ml ethanol; 
500 ml of this stock solution q.s. 1000 ml contains 1.0 mg/ 
ml etc~ for 0.5 and 0.25 mg/ml standard solutions. Figure 
5 demonstrates the standard curve for quantitative determina-
tion of ethanol by the enzymatic method of' Jones et al., 
(1970). The least squares regression line is linear the Y 
intercept is 0.00128 the slope 0.085, therefore ethanol 
levels may be determined by: 
x = y - b M where, X is ethanol/mg/ml: Y is . optical 
density; b is the Y intercept and M is the slope. 
Ethanol Intoxication: 
The animals were exposed continuously for 5 or 7 days 
in the ethanol vapor chamber to an air-ethanol mixture ob-
tained by mixing two streams of air; one directly to the 
chamber at a rate of 5.0 liters/min. and another bubbled 
through 9J% ethanol in a gas-washing bott~e at a rate of 
from 0.45 liters/min to 0.95 liters/min. · 
Rats were exposed to ethanol at a specific rate for 
the first 24 hours followed by gradual increases in ~he 
ethanol vapor flow-rate every 24 hours until the final day 
of the intoxication period. Three protocols of ethanol 
vapor exposure were emplo ed as follows: 1. First 24 hours 
ethanol vapor flow-rate was 0.45 liters/min, 24-48 hour~ 
-·,~-··· ,. __ __. .. _i, i~ ..,. ---------- ...... _ .. --·-- -~-
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Figure 5. STANDARD CURVE FOR QUANI'ITATIVE DETERMINATION OF EI'HANOL 
IN BIOOD. The enzymatic method of Jones et al., (1970) 
was used. 
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0.5 liters/min, 48-72 hours 0.55 liters/min, 72-96 hours o.6 
liters/min and 96-120 hours 0.6 liters/min. 2. First 24 hours 
ethanol vapor fLow-rate was 0.55 liters/min, 24-48 hours o.6 
liters/min, 48-72 hours 0 . 7 liters/min, 72-96 hours o.8 
liters/min and 96-120 hours 0.1 liters/min. J. First 24 
hours ethanol vapor flow-rate was 0.55 liters/min , 24-48 
hours o.6 liters/min, 48-72 hours 0.7 liters/min, 72-96 hours 
o.8 liters/min, 96-120 hours 0.85 liters/min, 120-144 hours 
0.9 liters/min and 144-168 hours 0.95 liters/min. The three 
ethanol vapor exposure-protocols were subsequently denoted 
as 5 DAY LOW, 5 DAY HIGH and 7 DAY HIGH, respectively. 
All animals were exposed to ethanol vapors in groups 
of six rats. Prior to exposure and every 24hours thereafter 
all animals were weighed and injected with pyrazole (68 mg/ 
kg, i.p.), except on the final day when weight was recorded 
but no pyrazole was administered . Goldstein and Pal (1971), 
found that pyrazole stabilizes the blood ethanol levals in 
mice inhaling ethanol vapors as well as inhibiting ethanol 
metabolism as shown by Theorell .£,:£al., (1969) and Lester 
et al., (1968). 
The air-ethanol flow-rates and daily doses of pyrazole 
maintained blood ethanol levels in 5 DAY LOW exposed rats 
at 0.8J ± 0.09 mg/ml/blood after 24 hours to 1.80 + 0.05 
mg/ml/blooa after 120 hours of ethanol inhalation. In 5 
DAY HIGH exposed rats levels were 0 . 78 ± 0.14 mg/ml/blood 
after 24 hours to 1.98 + 0.16 mg/ml/blood after 120 hours 
i!.:..._.. __ __ 
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of ethanol inhalation. In 7 DAY HIGH exposed rats levels 
were 0.93 ~ 0.20 mg/ml/blood after 24 hours to 2.19 + 0.14 
mg/ml/blood after 168 hours of ethanol inhalation. Table 1 
shows the mean blood ethanol levels on each day of ethanol 
inhalcttio·n in groups inhaling ethanol under each of the 
three protocols. Figure 6 demonstrates a linear relation-
ship between the blood ethanol level and the ethanol vapor 
concentration within the inhalation chamber. The data re-
presented in Figure 6 was prepared by plotting the mean 
blood ethanol levels of rats after exposure for 24 hours 
to ethanol vapors at flow-rates of o.45-0.9 liters/min re-
gardless of the duration of ethanol inhalation at other 
flow-rates. For example, rats exposed to the 5 DAY LOW 
protocol inhaled ethanol vapors at flow-rates of o.6 liters/ 
min from 72-120 hours of exposure, while rats in the 5 DAY 
HIGH group inhaled ethanol vapors at a flow-rate of 0.6 
liters/min from 24-48 hours of exposure. The blood levels 
of all rats at these flow-rates were used for mean deter-
minations. Chamber ethanol concentrations were taken from 
Figure 4. Figure 7 demonstrates a linear relation between 
blood ethanol levels and the cumulative doses of pyrazole. 
Since, both ethanol vapor concentration and pyrazole are 
inc r easing during ethanol inhalation it is not possible, 
from these retrospective comparisons, to conclude that 
pyrazole itself is not responsible for the increasing 
blood ethanol levels. However, Goldstein (1972a.); has 
shown that pyra zole does not cause increases in the blood 
TABLE 1 
BLOOD ETHANOL LEVELS IN RATS INHALING ETHANOL VAPORS 
MEAN BLOOD ETHANOL + S.E. (MG/ML') 
DAYS 
WITHDRAWN 
TREATMENTS 1 2 3 4 5 6 7 24 HOURS 
--
5 DAY LOW 0.83 0.95 1. 61 1. 63 1. 80 0.09 
+ 0.09 + 0.06 + 0.02 + 0.05 + 0.05 
- -
+ 0.02 
- - -( 3) ( 3) ( 3) ( 3) ( 3) ( 3) ~' 5 DAY HIGH* 0.78 0.99 1. 85 1. 86 1. 98 - - 0.18 + 0.14 + 0.02 + 0.07 + 0.10 + 0.16 + 0.04 
-
I-
(3) ( 3) ( 3) ( 3) ( 3) (6) 
7 DAY H.IGH** 0.93 1. 27 1. 77 1. 81 1. 98 1. 90 2.19 0.36 I 
+ 0.02 + 0.16 + 0.08 + 0.11 + 0.13 + 0.12 + 0.14 + 0.01 I 
- - - - - - - - I q ( 3) ( 3) ( 3) ( 3) ( 3) ( 3) ( 6) ( 3) 
ANALYSIS OF VARIANCE 
SOURCE d. f. SS MS F p i I 
DAYS 4 8.2745 2.0686 73.16 <0.005 ~ I 
CONCENTRATIONS 2 0.2861 0.1431 5.06 <0.025 
t INTERACTION 8 0.1793 0.0224 0.79 N.S. ERROR 30 0.8482 0 . 0283 r 
TOTAL 44 9.5881 t · 
* P<0.05; **P<0.005vs. 5 DAY LOW 
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Figure 6. . REIATIONSHIP BEIWEEN CHAMBER ETHANOL VAPOR CCNCENTRATION 
AND THE MEAN BUX)D ETHANOL LEVEI.S OF RATS INHALING 
ETHANOL. Each J?Oint represents the mean blood ethanol 
level for 3, 3, 9, 12, 6, 6, 3 and 6 rats corresJ?Onding 
to chamber ethanol vaJ?Or concentrations of 8~8, 10.8, 
14.0, 17.5, 23.0, 25.1, 25.5 and 26.1 mg/liter, re-
spectively. 
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Figure 7. REIATIONSHIP BE'IWEEN THE CUMUI.ATIVE OOSES OF PYRAZOLE AND 
THE MEAN BIOOD ETHANOL LEVELS OF RATS INHALING ETHANOL. 
Rats were administered ethanol by either the 5 DAY J.J:J./i!, 
5 DAY HIGH or 7 DAY HIGH protocol and administered pyra-
zole 68 mg/kg/day, i. p. for 5 or 7 days. Each point 
represents the mean blood ethanol level of 9 rats, ex-
cept after a cumulative dose of pyrazole of 408 and 476 
mg/kg where the N = 3 and 6, respectively. 
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ethanol concentrations when injected daily while et~anol 
concentrations in the inhalation chamber are held constant. 
Ethanol Tolerance: 
Measurement of tolerance to ethanol was done by measur-
ing the onset and duration of ethanol-induced narcosis . 
Ethanol~induced narcosis was measured in rats . after either 
72 hours of ethanol withdrawal after exposure to the 5 DAY 
HIGH protoqol, w{thdrawal for 96 hours after five days of 
pyrazole treatment (68 mg/kg/day; i.p.), corresponding to 
72 hours of ethanol withdrawal or after no pretreatment. On~ 
set of narcosis was defined as the interval between injec-
tion and the loss of the right1ng reflex, duration as the 
interval between onset and recovery of the end point , which 
was defined as two rightings within one minute. For example , 
when a rat lying on its back spontaneously righted i~self 
it was immedia~ely placed upon its back again if it again 
righted itself in one minute time was recorded if it did 
not time was continued. Rats were starved 24 hours prior 
to ethanol administration (5 g/kg, so% in saline, i.p.). 
Ethanol Withdrawal: 
Rats were withdrawn after continuous inhalation of 
ethanol vapors 24 hours after their lastinjection of pyra-
zole and placed in individual cages . At first rats wer~ 
observed every 2 hours for 16 hours then at longer inter-
vals the:reafter. Final intervals for observation were at 
O, 12, 24, J6, 48 and 72 hours of withdrawal; ooservation 
duration was one hour. Measurement of withdrawal i~~ensity 
was done via a ethanol withdrawal intensity scale (see 
Results, Table J). 
Withdrawal Aggression: 
Rats were administered apomorphine or d-amphetamine at 
various doses and at vari us time periods during ethanol 
withdrawal. Apomorphine or d~amphetamine were dissolved in 
distilled water and injected intraperitoneally. The rats 
were aggregated immediately after injection in groups or 
three rats and observed for aggressive behaviors. Three 
parameters of aggression were measured, attacks and bites 
which were counted and displayed digitally, rearing which 
was measured in seconds and displayed digitally and vocali-
zations which were measured automatically via audio relay. 
Attacks and bites arid rearing were measured with the help 
of Lehigh Valley Electronics programmable digital counters 
and ATCOTROL clock, while vocalizations were measured us-
ing Audio Threshold Detection Relay-761G Scientific Proto-
type Mfg. Corp., New York, N.Y. Pretreatment with either 
ethanol, chlordiazepoxide or morphine was administered JO 
minutes prior to injection of apomorphine in experiments· 
designed to measure the effectiveness of ethanol, chlor-
diazepoxide or morphine in reducing apomorphine-induced 
aggression in ethanol withdrawn rats. 
.,_...., _______ ~........,~--.-....--~ 
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Statistical Analysis: 
Statistical analysis performed on data obtained using 
the ordinal rating scale were done using the non-parametric 
Mann-Whitney U Test and the Kruskal-Wallis Non-Parametric 
One-Way Analysis of Variance (Siegel, 1956). Parametric 
analysis were performed using the Student's "t" Test, Re-
gression Analysis, One and Two-Way Analysis of Variance with 
preplanned one degree of freedom comparisons (Snedecor and 
Cochran, 1967). 
I ' 
-....t..ll..! 
RESULTS 
The results obtained from the study of continuous in-
halation of ethanol vapors in rats are desdribed in the 
following sections: 
A) Ethanol-induced narcosis 
B) Ethanol withdrawal signs 
c) Drug treatment of acute ethanol withdrawal 
' D) Drug-induced aggression during ethanol withdrawal 
E) Drug treatment of apomorphine-induced aggression 
during ethanol withdrawal 
F) . Mortality during ethanol withdrawal 
. . . I. 
---~---LU..c 
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A) EFFECT OF ETHANOL INHALATION ON ETHANOL-INDUCED NARCOSIS 
IN RATS 
The onset and duration o:f ethanol-induced , narcosis wa·s 
measured in rats 72 hours a:fter withdrawal :from the 5 · DAY 
HIGH protocol or 96 hours a:fter :five days o:f pyrazole pre-
t~eatment (68 mg/kg/day, i.p.) c~rresponding to 72 hours o:f 
ethanol wi~hdrawal or no pretreatment. Onset o:f narcosis 
was de:fined as the interval between injection o:f ethanol 
and the ·l .oss o:f the righting re:flex. Duration o:f ethanol 
narcosis was de:fined as the interval between onset and re-
covery o:f the end point which was de:fined as 2 rightings 
within one minute. For example, when a rat lying on its 
back spontaneously righted itsel:f it was immediately placed 
on its back again, · i:f it aga'in righted i tsel:f time was re-
corded, i:f it did not time was continued. Rats were starved 
24 hours prior to ethanol administration (5 g/kg, so% in 
saline, i.p.). Table 2 summarizes the e:f:fects o:f the above 
pretreatments on the onset and duration o:f ethanol-induced 
narcosis. Pretreatment o:f ethanol plus pyrazole (5 DAY 
HIGH) significantly increased the onset and decreased the 
duration o:f ethanol-induced narcosis. , Pyrazole pretreat-
ment alone did not alter ethanol-induced narcosis. 
B) ETHANOL WITHDRAWAL SIGNS 
Seven signs 01· wi thdrawal were observed in rats with-
drawn :from inhalation o:f ethanol vapors along with daily 
inject ions o:f pyrazole. They are piloerection, abnormal 
· posture, tremors, convulsions, headshakes, tail-li:fts and 
I 
. 1~.IJ: .. 1. -
TABLE 2 
EFFECT OF PYRAZOLE OR ETHANOL PLUS PYRAZOLE ON 
ETHANOL-INDUCED NARCOSIS 
51 
NUMBER ETHANOL NARCOSIS 2 (MINUTES, MEAN+S.E. 
PRETREATMENT! N DEAD ONSET p3 DURATION p3 
ATR 
+ 16 5 66 + 8 825 + 56 
- -SALINE 
AIR 
+ 17 5 70 + 8 n 1• s. 846 + 64 n.s. 
-PYRAZOLE 
ETHANOL 
* + 19 6 86 + 7 <0.05 438 + 35 < 0. 001 
- -PYRAZOLE 
1Pretreatment was that of the 5 DAY HIGH protocol. 
25 g/kg ethanol 50% in saline administered (i.p.) after 72 
hours of ethanol withdrawal, 96 hours after the last 
pyrazole injection. 
3student's "t" Test vs Air+ Saline 
*Student's "t" Test vs Air+ Pyrazole P < 0.001 
.• 
i' 
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deaths. Piloerection, abnormal posture, tremors and con-
vulsions were observed at regular intervals during with-
drawal and their intensity measured by the rating scale 
shown iri Table J. The wi"thdrawal signs OI headshakes (ra-
pid shaking of the head and occasionally the entire body) 
and tail-lifts (sudden arching of the tail over the back) 
r 
' 
were counted and recorded at regular in"tervals. All with-
drawal signs were measured duI~ing an obs'erva ti on period, 
which was one hour in duration at each observation time, 
except deaths which were cumulated up to and including 72 
hours after wi"thdrawal. The ethanol withdrawal syndrome, 
which consisted of the withdrawal signs of piloerection, 
abnormal posture, tremors and convulsions, used here as an 
expression of the intensity of the ethanol withdrawal reac-
tion, was calculated by summing the scores each rats re-
ceived for the four rated withdrawal signs and then ob-
taining a median value at each of the hours of ethanol with-
drawal observation. 
1. Effect of Different Ethanol Inhalation Protocols on the 
:T'i1tensi ty of the Ethanol Withdrawal Syndrome. 
The intensity of the ethanol withdrawal syndrome in 
rats withdrawn after three different protocols of ethanol 
inhalation is shown in Figure 8. The intensity of the 
etha~ol withdrawal syndrome in rats, as measured by the 
ethanol withdrawal scale (Table J), after withdrawal from 
the 5 DAY LOW protocol was relatively mild. The peak in-
:: ~,.J- ' .:. . 
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TABLE 3 
ETHANOL WITHDRAWAL INTENSITY RATING SCALE 
WITHDRAWAL 
SIGN 
PILOERECTION 
ABNORMAL 
POSTURE 
TREMOR 
CONVULSION 
INDUCED BY 
AIR-BLAST 
DESCRIPTION RATING 
NO PILOERECTION 0 
SLIGHT PILOERECTION 1 
MARKED PILOERECTION 2 
SEVERE "PUFFED APPEARANCE" PILOERECTION 3 
NO ARCHED BACK, TIP-TOE STANCE OR 
ROTATION OF HINDLIMBS 
SLIGHTLY ARCHED BACK 
MARKED ARCHING OF BACK 
MAXIMUM ARCHED BACK WITH EITHER OR 
BOTH A TIP-TOE STANCE OR OUTWARD 
ROTATION OF THE HINDLIMBS 
0 
1 
2 
3 
NO TWITCHES, JERKS OR TREMBLING 0 
SPORATIC TWITCHING, JERKING OR TREMBLING l 
MARKED JERKING AND TREMBLING INVOLV-
ING THE ENTIRE BODY 2 
SEVERE, VIOLENT JERKING AND TREMBLING 
OF LONG DURATION, MAY VOCALIZE, 
APPROACHES SPONTANEOUS CONVULSION 3 
NO CONVULSION 
CLONIC RUNNING 
TONIC-CLONIC CONVULSION 
TONIC-CLONIC CONVULSION RESULTING 
0 
1 
2 
IN DEATH 3 
MAXIMUM 12 
.'~- ............ ._ _ ____. .. .... 1' '. L . . l -~1!;.; - --------------
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Figure 8. EFFECT OF THREE EI'HANOL EXPOSURE PRO'IOCOI.S ON 'lliE INI'ENSITY 
OF THE EI'HANOL WITHDRA.WAL SYNDRCME. Rats were withdrawn 
from inhalation of ethanol vapors after exposure to either 
the 5 DAY LOW protocol (0.45-0.60 liters/mino--o), the 
5 DAY HIGH protocol (0.55-0.90 liters/mino---o), or the 7 
DAY HIGH protocol (O. 55-0. 95 liters/min Jr--:&) • Control 
rats were administered pyrazole (D-- - -i:I ) or no treatment 
(-- ) • Rats withdrawn from ethanol inhalation and con-
trols were observed and scored fran 0-3 for piloerection, 
abnormal posture, tremors and convulsions at regular hour-
1 y interval s. Scores were combined and the median score 
determined. Untrea.ted control N = 30 at all ti.Ire :periods, 
pyrazole treated N = 18 at all time periods, 5 DAY I.J:JtJ 
N = 6 at O, 12, and 24 hours; N = 5 at 36 and 48 hours, 5 
DAY HIGH N = 48, 36, 42, 35, and 40 at O, 12, 24, 36, and 
48 hours, respect ' vely , 7 DAY HIGH N = 6 , 6, 18 , 10 and 
......_.._ ....... ~ .. --... -i.l.._ .... __ . 
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tensity occurred after 24 hours of withdrawal with a median 
score of 4.5. The peak intensity of the ethanol withdrawal 
syndrome in rats after withdrawal from either the 5 DAY 
HIGH or 7 DAY HIGH protocols occurred at J6 hours of with-
drawal with median scores of 6.0 and 7.5, respectively. The 
peak intensity of the ethanol withdrawal syndrome in rats 
exposed to the 5 DAY LOW protocol was significantly less 
than rats exposed to the 5 DAY HIGH or 7 DAY HIGH protocols 
(P< 0.001 Mann-Whitney U Test). The peak intensity of the 
5 and 7 DAY HIGH protocols were not · signiI icantly different. 
Therefore, the 5 DAY HIGH protocol was selected for most 
studies, since the longer inhalation protocol did not sig-
nificantly increase the withdraw~l intensity. Goldstein 
and Pal (1971), have shown that some ethanol withdrawal 
signs can occur at low levels of intensity in un~reated and 
pyrazole treated mice. Therefore, control rats were ad-
ministered pyrazole .for 5 days and · control rats which were 
not pretreated were observed ana. rat·ed as were ethanol 
withdrawn rats. These resul .ts are also seen in Figure ·s. 
See Appendi:ic I for individual values contained in Figure 8. 
2. Effect of Pyrazole on the Body Weight of' Rats Inhaling 
Ethanol 
Table 4 summarizes the ef'fects of' chronic · administra-
tion of pyrazole or ethanol plus pyrazole on the body 
weight of rats. Food and water were available ad libitum 
at ' all times to these rats. Untreated rats gained 6% of 
their starting weight over· the five-day period. Ra ts ad-
,, '· !" 
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TABLE 4 
EFFECT OF PYRAZOLE ON THE BODY WEIGHT OF RATS INHALING ETHANOL 
MEAN + S.E. 
PRE-DRUG POST-DRUG WEIGHT CHANGE 
GROUP TREATMENTl N WEIGHT WEIGHT GRAM % p2 
1 NONE 20 311 + 5 329 + 5 + 19 + 1 + 6 + 0.4 
- -
AIR 
2 + 48 295 + 10 248 + 10 - 47 + 2 - 17 + 0.7 1 vs 2, < 0.001 
PYRAZOLE 
2 vs 3,(0.05 
ETHANOL 
3 + 30 290 + 7 254 + 7 33 + 4 12 + 1.4 1 vs 3 , < o • oo 1 
-PYRAZOLE 
1 Treatment was that of the 5 DAY LOW protocol. 
2student's "t" Test. 
."• 
·.,,I. 
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ministered pyrazcile (68 mg/kg/day) lost 17% of" their start-
ing weight a1·ter f'ive dA.ys of' treatrf1ent and wsight'e-d sig:... 
nificantly less than untreated controls . Although rats in-
haling ethanol along with d~ily injections of pyrazole lost 
12% of their starting weight and we~ghted signiiicantl~. 
less than untreated controls their we.ight loss was signif'i-
cantly less than r~ts treated with only pyrazole. Data ex-
presse.d as weight change (Table 4) was calculated as fol-
lows: grams lost or gained was calculated by subtracting 
the pre-drug weight from the post-drug weight of each rat 
and then obtaining a mean and standard error for all rats; 
% weight . change was calculated by divid~n~ the grams lost 
by the pr,e-drug weigh-c of each rat ana then obtaining a 
mean and standard ~rro~ for all r~ts. 
3. Effect of Ethan61 Withdrawal Duration on the Intens~ty 
of Ethanol Withdrawal Signs 
The data in Figure 9a. demonstrates the effect of the 
duration of ethanol withdrawal on the frequency with which 
each ra~ing of withdrawal intensity was assigned to the 
four withdrawal signs piloerection, abnormal posture, trem-
ors and convulsions. In order to clearly identify the 
hour at which each withdrawal sign reaches peak intensity 
the data in Figure 9a is represented in Figure 9b. as the 
percent frequency with which ratings of either 0 or 1 and 
2 or 3 were assigned. The highest frequency of maximum 
(2 or 3) and lowest frequency of minimum (o or 1) scores 
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Figure 9b. EFFECT OF WITHDRAWAL DURATION UPON THE INI'ENSITY OF ETHANOL 
WITHDRAWAL SIGNS. Shown are the percent frequency with 
which withdrawal scores were assigned to rats withdrawn 
from ethanol inhalation under the 5 DAY HIGH protocol for 
the withdrawal signs of piloerection (o e) , abnormal 
posture ( o--o) , tremors (.&---A ) and convulsions (tr----6 ) • 
See Figure 9a. for N at each time period. 
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occurred at 36 hours of ethanol withdrawal. See Appendix 
II for data expressed in Figure$ 9a and 9b. 
Figure 10 demonstrates the effect of the duration of 
ethanol withdrawal on the occurrence of headshakes. Al-
though the mean number of headshakes are maximum at J6 
hours of withdrawal the variability is high. Although, un-
treated rats show a low frequency of headshakes, rats 
treated with pyrazole display a relatively high frequency 
of headshakes which are significantly greater than the fre..; 
quency observed in untreated rats (P < 0.0005, P < 0.0005, 
P < 0 • 000 5 , P < 0. 000 5 P < 0. 000 5 and P < 0 • QO 5 at 0, 12, 24 , 
J6, 48 and 72 hours. Withdrawal headshakes are signifi-
cantly less than pyrazole treated rats at 0 hours of with-
drawal (P < 0.0005) and greater than pyrazole treated rats 
at J6 and 72 hours of withdraw.al (P<0.001 and P(0 .• 05, 
respectively) . 
Figure 11 demonstrates the effect of the duration of 
ethanol withdrawal on the frequency of tail-lifts. Tail-
lifts we~e not seen in untreated controls and only at very 
low levels at 0 hours of withdrawal in pyrazole treated 
rats. However, in ethanol withdrawn rats the mean number 
of tail-lifts are maximum at 24 hours of withdrawal, but 
do not dec~ine until 48 hours of ethanol withdrawal. Tail-
lifts are significantly greater than pyrazole controls at 
12, 24 and J6 hours of ethanol withdrawal ( P < 0 .05, P < 0. 05 
and P < 0.01, respectively) . 
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72 
Figure 10. EFFECT OF THE DURATION OF ETHANOL WITHDRAWAL ON THE OCCURENCE 
OF HEADSHAKES. Rats withdrawn from inhalation of ethanol 
vapors under the 5 DAY HIGH protocol (o--o) , pyrazole 
treated rats (0---0) and untreated rats (~) were observed 
for one hour for headshakes. Untreated rats were observed 
at one time period. 5 DAY HIGH and pyrazole treated rats 
were observed at six time periods over a 72 hour period. 
Pyrazole treated rats N = 18 at all time periods, untreated 
rats N = 30 and ethanol exposed rats N = 48, 36, 42, 35, 40 
and 22 at 0, 12, 24, 36, 48 and 72 hours of ethanol with-
drawal. 
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Figure 11. EFFECT OF THE DURATION OF El'HANOL WITHDRAWAL ON THE 
OCCURRENCE OF TAIL-LIFTS. Ra ts withdrawn fran in-
halation of ethanol vai;:ors under the 5 Dl0l HIGH 
protocol (o---c), pyrazole treated rats (o--o) and 
untreated rats ( - ) were observed for one hour 
for tail-lifts. Untreated rats were observed at 
one bme period. 5 DAY HIGH and pyrazole treated 
rats were observed at six tirre periods over a 72 hour 
period. Pyrazole treated rats N = 18 at all ti.Ire 
periods, untreated rats N = 30 and ethanol exi;:osed 
rats N = 48, 36, 42, 35, 40 and 22 at 0, 12, 24, 36, 
48 and 72 hours of ethanol withdrawal. 
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c) DRUG TREATMENT OF ACUTE ETHANOL WITHDRAWAL IN RATS 
1. Effect of Ethanol on the Ethanol Withdrawal Signs 
Figure 12a. demonstrates the effect of orally adminis-
tered ethanol on the ethanol withdrawal signs. Ethanol 
(50% in saline, p.o.) was administered JO minutes prior to 
observation of withdrawal signs after 36 hours of ethanol 
withdrawal. In order to clearly identify the effect of 
ethanol on the ethanol withdrawal signs the data in Figure 
12a. is expressed in Figure 12b. as the percent frequency 
of rats rated either 0 or 1 and 2 or J. It can be seen in 
Figure 12b. that as the dose of ethanol administered in-
creases the frequency with which minimum ·scores · (o or ·l) 
were assigned increases, while the frequency of maximum 
scores (2 or J) decreases representing a decrease in the 
intensity of the ethanol withdrawal signs. See Appendix 
III for data contained in Figure 12a. and 12b. All si~ns 
of ethanol withdrawal were significantly reduced by ad-
mi nis tra t i on of ethanol ( piloerection P < 0. 02, abnormal 
posture P< 0.001, tremors P< b.001 and convulsions P( 0.001, 
Kruskal-Wallis Non-parametric One-Way Analysis of Variance)~ 
It can be seen in Figures 9a and 9b that all of the rated 
ethanol withdrawal signs follow a similar time course in 
i ntensity development and in Figure 12a and 12b that all of 
these ethanol withdrawal signs are reduced by reinstating 
ethanol administration. Therefore, all four rated ethanol 
withdrawal signs were combined irtto an ethanol withdrawal 
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Figure 12b. EFFECT OF ORALLY ADMINISTERED ETHANOL ON ETHANOL-WITH-
DRAWAI.. SIGNS. ShONn are the withdrawal scores for rats 
withdrawn 36 hours after exrosure under the 5 DAY HIGH 
protocol for the withdrawal signs of Piloerection 
(o--o) , Abnormal Posture ( o--o) , Tremors (Jr--a ) and 
Convulsions (~). Ethanol was administered orally 
30 minutes prior to observation for one hour. See 
Figure 12a. for N at each dose shONn. 'I 
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syndrome measurement, used here as a simplified expression 
of the intensity of the ethanol withdrawal reaction. This 
was done by summing the scores each rat obtained for each 
of the four rated withdrawal signs (maximum 12) and then 
obtaining a median withdrawal score. Figure lJ demonstrates 
the effect of ethanol on the ethanol withdrawal syndrome . 
Doses of 2.0 g/kg or greater of orally administered ethanol 
significantly reduced the ethanol withdrawal syndrome 
(P <. 0.001 Mann-Whitney U Test). The effect of ethanol on 
the ethanol withdrawal syndrome was dose-dependent (r=0.96, 
P< 0.025, regression analysis). See Appendix IV for data 
contained in the ethanol withdrawal syndrome Figure lJ. 
·Table 5 summarizes the effect of orally administered 
ethanol on the frequency of headshakes. Ethanol was ad-
minis t ered JO minutes prior to observation at J6 hours of · 
ethanol withdrawal. A dose of ethanol 2.0 g/kg, 4 . o g / kg 
and 8.0 g /kg significantly reduced the frequency of head-
shake~ compared to un~reated ethanol withdrawn rats 
(P< 0.005, P<0.001 and P<0.0005, respe.ctively Student's 
"t" Test). 
Ta ble 6 summarizes the effect of orally administered 
ethanol on . ~he frequency of tail-lifts. Ethanol was ad-
mi n i s te r e d JO minutes prior to observation at J6 hours of 
ethanol wi thdrawal. A dose of 4.o g/kg and 8.0 g/kg sig-
"' 
nificantly reduced the frequency of tail-lifts compared to 
untreated ethanol withdrawn rats (P< 0.01 and P< 0.0005, 
respectively' Student's "t" Test). 
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Figure 13. DOSE-DEPENDENT EFFECT OF ORALLY ADMINISTERED ETHANOL ON THE 
ETHANOL WITHDRAWAL SYNDROME. Rats were withdrawn from in-
halation of ethanol vapors for 36 hours then administered 
ethanol (50% p.o.) 30 minutes prior to 1 hour of observation 
for withdrawal signs of piloerection, abnormal posture, 
tremors and convulsions. Scores were combined and the 
median determined at each dose. Ethanol administration 
significantly reduced the withdrawal scores (Kruskal-Wallis 
Non-parametric One-Way Analysis of Variance P < 0.001). Re-
duction of withdrawal scores were significantly less in 
ethanol treated rats at a dose of 2.0 g/kg, 4.0 g/kg and 
8.0 g/kg (P< 0.001 Mann-Whitney U Test). N = 35, 11, 10, 
11 and 11 at ethanol doses of 0, 0.5, 2.0, 4.0 and 8.0 
g/kg, respectively. 
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TABLE 5 
EFFECT OF ETHANOL UPON THE FREQUENCY OF HEADSHAKES 
ETHANOL1 2 (G/KG) N HEADS HAKES/HR, MEAN + S.E. p 
-
0 35 5.7 + 1.14 
-
0.5 11 6.1 + 2.17 N.S. 
-
2.0 10 2.3 + 0.98 < 0. 005 
-
4.0 11 1. 4 + 0.54 < 0. 001 
-
8.0 11 1.1 + 0.49 < 0. 0005 
-
1Ethanol administered orally (50% in saline) 30 minutes 
prior to 1 hour of observation at 36 hours of ethanol with-
drawal. 
2student's "t' Test vs O ethanol. 
----~- - - ......... ' ": l · 
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TABLE 6 
EFFECT OF ETHANOL UPON THE FREQUENCY OF TAIL-LIFTS 
ETHANOL1 
p2 (G/KG) N TAIL-LIFTS/HR, MEAN + S.E. 
0 35 0.60 + 0.175 
-
0.5 11 0.82 + 0.325 N.S. 
-
2.0 10 0.30 + 0.153 N.S. 
-
4.0 11 0.09 + 0.091 < 0. 01 
-
8.0 11 0.00 + o.oo <0.0005 
-
1Ethanol administered orally (50% in saline) 30 minutes 
prior to 1 hour of observation after 36 hours of ethanol with-
drawal. 
2student's "t" Test vs 0 Ethanol. 
( ·· .. · 
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2. Effect of Chlordiazepoxide on the Ethanol Withdrawal Syn-
drome 
Figure 14 demonstrates the effect of intraperitoneally 
injected chlordiazepoxide on the ethanol withdrawal syndrome 
in rats withdrawn from inhalation of ethanol. See Appendix 
III for percent frequency for which each rating of withdraw-
al intensity was assigned for the four rated ethanol with-
drawal signs piloerection, abnormal posture, tremors and 
convulsions. A dose of chlordiazepoxide (i.p.) 40 mg/kg, 
80 mg/kg and 160 mg/kg significantly reduced the ethanol 
withdrawal syndrome (P < 0.005, P < 0.001 and P < 0.001 Mann-
Whitney U Test). See Appendix IV for data expressed in Fig-
ure 14. Chlordiazepoxide was administered (i.p.) JO min-
utes prior to observation for 1 hour at J6 hours of ethanol 
withdrawal. The reduction of the ethanol withdrawal syn-
drome by chlordiazepoxide was dose-dependent (r=0.98, P(0.001, 
regression analysis). 
Table 7 summarizes the effect 01· administration of 
chlordiazepoxide on the frequency of headshakes. Chlordi-
azepoxide was administered (i.p.) JO minutes prior to ob-
servation for 1 hour at J6 hours of ethanol withdrawal. A 
dose of chlordiazepoxide 160 mg/kg significantly reduced 
the frequency of headshakes compared to untreated ethanol 
withdrawn rats (P< 0.0005, Student's "t" Test). 
Ta ble 8 summarizes the effect of administration of 
chlordiazepoxide on the frequency of tail-lifts. Chlor-
• 1 
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Figure 14. DOSE-DEPENDENT EFFECT OF INTRAPERITONEALLY ADMINISTERED 
CHIORDIAZEPOXIDE ON THE ETHANOL WITHDRAWAL SYNDROME. 
Rats were withdrawn from inhalation of ethanol vapors 
for 36 hours then administered chlordiazepoxide (i.p.) 
30 minutes prior to 1 hour of observation for withdraw-
al signs of piloerection, abnormal posture, tremors 
and convulsions. Scores were combined and the median 
determined at each dose. Chlordiazepoxide administration 
significantly reduced the withdrawal scores (Kruskal-
Wallis Non-parametric One-Way Analysis of Variance P < 0. 001) • 
Reduction of withdrawal scores were significantly less in 
chlordiazepoxide treated rats at a dose of 40 mg/kg, 80 
mg/kg and 160 mg/kg (P< 0.005, P< 0.001 and P< 0.001, re-
spectively, Mann-Whitney U Test). N = 35, 12, 10, 12, 12, 
and 12 at chlordiazepoxide doses of 0, 10, 20, 40, 80 and 
160 mg/kg, respectively. 
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TABLE 7 
EFFECT OF CHLORDIAZEPOXIDE UPON THE FREQUENCY OF HEADSHAKES 
CHLORDIAZEPOXIDEl p2 (MG/KG) N · HEADSHAKES/HR, MEAN + S.E. 
0 35 5.7 + 1.14 
-
10 12 6.0 + 1.70 N.S. 
-
20 10 5.4 + 1.48 N.S. 
-
40 12 4.4 + 0.80 N.S. 
-
80 12 3.6 + 0.92 N.S. 
-
160 12 o.o + o.oo <0.0005 
-
lchlordiazepoxide administered (i.p.) 30 minutes prior to 
1 hour of observation at 36 hours of ethanol withdrawal. 
2 Student's "t" test vs 0 mg/kg Chlordiazepoxide. 
., 
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TABLE 8 
EFFECT OF CHLORDIAZEPOXIDE UPON THE FREQUENCY OF TAIL-LIFTS 
CHLORDIAZEPOXIDE1 
p2 (MG/KG) N TAIL-LIFTS,lHR, MEAN + S.E. 
0 35 0.60 + 0.175 
-
10 12 0.75 + 0.304 N.S. 
-
20 10 0.50 + 0.220 N.S. 
-
40 12 0.25 + 0.130 N.S. 
-
80 12 o.oo + 0.00 < 0. 001 
-
160 12 0.00 + 0.00 < 0. 001 
-
lchlordiazepoxide administered (i.p.) 30 minutes prior to 
observation for 1 hour after 36 hours of ethanol withdrawal. 
2student's "t" Test vs 0 mg/kg Chlordiazepoxide. 
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diazepoxide on the freqti~nty - of tail-lifts. ChlorCliaze-
p .oxide was administered ( i. p.) JO minutes prior to obs er-
vation for 1 hour at J6 hours of ethanol withdrawal. A 
dose of 80 mg/kg and 160 mg/kg of chlordiazepoxide signif-
icantly reduced the frequency of tail-lirts when compared 
to untreated ethanol withdrawn rats (P< 0.001 and P( 0.001, 
respectively Student's "t" Test). 
J. Effect of Morphine Sulfate on the Ethanol Withdrawal 
Syndrome 
Figure 15 demonstrates the effect of intraperitoneally 
administered morphine sulfate on .the ethanol withdrawn syn-
drome in rats withdrawn from inhalation of ethanol. See 
Appendix III for percent frequency for which each rating 
of withdrawal intensity was assigned for the four rated 
ethanol withdrawal signs piloerection, abnormal posture, 
tremors and convulsions. A dose of morphine sulfate (i.p.) 
10 mg/kg, 20 mg/kg and 40 mg/kg significantly reduced the 
ethanol withdrawal syndrome (P<0.01, P< 0.001 and P~0.001, 
respective.Ly Mann.:.Whitney U Test). See Appendix IV for 
data expressed in Figure 15. Morphine sulfate was ad-
ministered (i.p.) JO minutes prior to observation for 1 
hour at J6 hours of ethanol withdrawal. The reduction of 
the ethanol withdrawal syndrome by morphine sulfate was 
dose-dependent (r= 0.99, P< 0.05 regression analysis). 
Table 9 summarizes the effect of administration of 
morphine sulfate on the frequency of headshakes. Morphine 
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Figure 15. DOSE-DEPENDENT EFFECT OF INTRAPERITONEALLY ADMINISTERED 
MORPHINE SULFATE ON THE ETHANOL WITHDRAWAL SYNDROME. Rats 
were withdrawn from inhalation of ethanol vapors for 36 
hours then administered morphine sulfate (i.p.) 30 minutes 
prior to 1 hour of observation for withdrawal signs of 
piloerection, abnormal posture, tremors and convulsions. 
Scores were combined and the median determined for each 
dose. Morphine sulfate significantly reduced the with-
drawal scores (Kruskal-Wallis Non-parametric One-Way Ana-
lysis of Variance P < 0. 001) . Reduction of withdrawal 
scores were significantly less in morphine sulfate treated 
rats at a dose of 10 mg/kg, 20 mg/kg and 40 mg/kg (P< 0.01, 
P< 0.001 and P < 0.001, respectively, Mann-Whitney u Test). 
N = 35, 12, 12, 11 at doses of morphine sulfate,of O, 10, 
20, and 40 mg/kg, respectively. 
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TABLE 9 
EFFECT OF MORPHINE SULFATE UPON THE FREQUENCY OF HEADSHAKES 
MORPHINEl 
p2 (MG/KG) N HEADSHAKES/HR, MEAN ± S .E. 
0 35 5.7 + 1.14 
-
10 12 3.2 + 0. 9 0 ( 0. 05 
-
20 12 0.7 + 0.26 < 0.0005 
-
40 11 0.0 + o.oo <0.0005 
-
lMorphine sulfate administered (i.p.) 30 minutes prior to 
1 hour of observation at 36 hours of ethanol withdrawal. 
2student's "t" Test vs 0 mg/kg Morphine Sulfate. 
' . 
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sulfate was administered (i.p.) JO minutes prior to obser-
vation for 1 hour at J6 hours oI ethanol withdrawal. A 
dose of morphine sulfate 10 mg/kg, 20 mg/kg and 40 mg/kg 
significantly reduced the frequency of headshakes compared 
to untreated ethanol withdrawn rats (P< 0.05, P( 0.0005 
and P( ,0.0005, respectively Student's "t" Test). 
Table 10 summarizes the effect of administration of 
morphine sulfate on the frequency of tail-lifts. Morphine 
sulfate was administered (i.p.) JO minutes prior to obser-
vation for 1 hour at J6 hours of ethanol withdrawal. A 
dose of 20 mg/kg and 40 mg/kg significantly reduced the 
frequency of tail-lifts when compared to untreated ethanol 
withdrawn rats (P< 0.025 and P< 0.0005, respectively Stu-
dent's "t" Test). 
D) DRUG-INDUCED AGGRESSION DURING ETHANOL WITHDRAWAL IN 
RATS 
1. Effect of the Duration of Ethanol Withdrawal on Apo-
morphine-Induced Aggression in Ethanol Withdrawn Rats 
Rats withdrawn from inhalation of ethanol vapors were 
placed in individual cages until the iime of aggression 
testing. Table 11 summarizes the effect of ~dministration 
of apomorphine (2.50 mg/kg) to rats withdrawn from ethanol 
for various durations of time. Rats were addicted to eth-
anol using the 5 DAY LOW protoco·l. Analysis of variance 
of each of the parameters of ~ggression (attacks and bites, 
rearing and vocalizations) shows a significant effect of 
80 
TABLE 10 
EFFECT OF MORPHINE SULFATE UPON THE FREQUENCY OF TAIL-LIFTS 
MORPHINE1 
p2 (MG/KG} N TAIL-LIFTS/HR, MEAN + S.E. 
0 35 0.60 + 0.175 
-
10 12 0.33 + 0.140 N.S. 
-
20 12 0.17 + 0.112 < 0.025 
-
40 11 0.00 + 0.000 <0.0005 
-
lMorphine sulfate administered (i.p.) 30 minutes prior to 
1 hour of observation at 36 hours of ethanol withdrawal. 
2student's "t" Test vs O mg/kg Morphine Sulfate. 
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TABLE 11 
EFFECT OF THE DURATION OF ETHANOL WITHDRAWAL ON 
APOIDRPHINE-INDUCED AGGRESSION 
HOURSl RESPONSES/HOUR (MEAN + S .E, ) 
WITHDRAWN N2 ATI'ACKS + BITES REARING VOCALIZATIONS 
24 4 0 + 0 0 + 0 13 + 2 
72 8 0 + 0 0 + 0 0 + 0 
·-
24 4 150 + 46 927 + 426 643 + 242 
48 2 174 + 26 2211 + 719 1659 + 446 * 
72 4 308 + 33** 2500 + 228** 1767 + 184 ** 
Analysis of Variance of Attacks and Bites 
d.f. SS MS F p 
2 55129 27564 4.88 < 0.05 
7 39576 5654 
94705 
Analysis of Variance of Rearing 
d.f. SS MS F p 
2 5342717 2671359 4.86 < 0.05 
7 3843884 549126 
9186601 
Analysis of Variance of Vocalizations 
d.f. SS MS F p 
2 2858786 1429393 
7 1504630 214947 6.65 < 0.025 
9 4363416 
lAporrorphine (2.50 :m;r/kg) administered (i.p.) immediately prior to ag-
gregation. 
2N = number of groups, each group contains 3 rats. 
* P< 0.05; ** P<.0.025; *** P< 0.01, comparisons among 24, 48 and 72 hour 
withdrawn rats after ethanol + pyrazole treatment under 5 DN!. ID.fl 
protocol. 
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the duration of ethanol withdrawal on the intensity of apo-
morphine-induced aggression. Rats withdrawn for 72 hours 
display the most intense aggression which is significantly 
greater than all three parameters of aggression at 24 hours 
of ethanol withdrawal. 
2. Effect of the Dose of Apomorphine on Apomorphine-Induced 
Aggression in Ethanol Withdrawn Rats 
Table 12 summarizes the effect of various doses of apo-
morphine on apomorphine-induced aggression in rats withdrawn 
72 hours after inhalation of ethanol vapors (5 DAY HIGH). 
The analysis of variance shows a significant effect of the 
dose of apomorphine on all parameters of aggression. Fur-
ther analysis using one degree of freedom comparisons re-
vealed that a dose of 1 . 25 mg/kg apomorphine did not sig-
nificantly increase the intensity of any parameter of ag-
gression when compared to rats receiving no apomorphine 
treatment. However doses of 2.50 and 5.00 mg/kg apomor-
phine significantly increased a:ll parameters of aggression: 
compared to rats receiving no apomorphine treatment. Com-
parisons among treatments revealed that doses of 2.50 and 
5.00 mg/kg apomorphine significantly increased the in-
tensity of' aggression on all parameters when compare
1
d to 
rats treated with 1.25 mg/kg apomorphine. However, a dose 
of' 5.00 mg/kg apomorphine did not significantly increase 
the number of' attacks and bites when compared to rats 
treated with 2.50 mg/kg apomorphine · and in fact reduced 
', ·1,, 
~ __ :...tJ.\.i 
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TABIB 12 
APQM)RPHINE-JNDUCED AGGRESSION IN ETHA.."l\JOL WITHDRAWN RATS 
RESPONSES/HOUR, MEAN + S.E. 
AP()M)RPHINE 
(MG/KG) N2 ATI'ACKS + BITES REARING Vcx:'ALIZATIONS 
0 15 3 + 1 62 + 51 21 + 14 
1.25 3 18 + 6 304 + 196 74 + 36 
2.503 13 164 + 20 2052 + 198 1565 + 182 
5.00 3 185 + 17 1328 + 80 709 + 20 
p p p 
0 vs 1.25 n. s • . n.s. n.s. 
0 vs 2.50 < o. 005 .(. 0. 005 < 0. 005 
0 vs 5.00 < o. 005 < o. 005 <.0.005 
1.25 vs 2.50 < 0. 005 < 0. 005 < 0. 005 
1.25 vs 5.00 < 0. 005 < 0. 005 < o. 025 
2.50 vs 5.00 n.s. < 0.005 < 0. 005 
APOMORPHI:NE RESPONSES 0-30 MJN, MEAN + S.E. 
(MG/KG) N ATI'ACKS + BITES REARING VOCALIZATIONS 
-2.50 13 98 + 15 1023 + 156 821 + 131* 
5.00 3 141 + 8** 1050 + 59 552 + 13 
RESPONSES 30-60 MIN, ME'AN + S.E. 
ATI'ACKS + BITES REARil.:JG VOCALIZATIONS 
2.50 . 13 65 + 10 975 + 114*** 745 + 94*** 
5.oo3 3 43 + 10 278 ± 42 160 + 24 
ANALYSIS OF VARIANCE OF A'ITACKS AND BITES/HOUR 
SOURCE d.f. SS MS F p 
OOSES -3- 226263 75421 30.76 <0.005 
ER..-qOR 30 73548 2452 
TOTAL 33 299811 
ANALYSIS OF VARIANCE OF REA...'RING/HOUR 
SOURCE d.f. SS MS F p 
DOSES -3- 29308542 9769514 126.35 < 0. 005 
ERROR 30 2319598 77320 
TOI'AL 33 31628140 
ANALYSIS OF VARIANCE OF VOCALIZATIONS/HOUR 
SOURCE d.f. SS MS F p 
DOSES -3- 17794972 5931657 34.12 < 0. 005 
ERROR 30 5215120 173837 . 
-TOI'AL 33 23010092 
lApo:rrorphine administered (i.p.) at 72 hours of ethanol withdrawal, 5 DAY 
HIGH protocol. 
2N = number of groups, each group contains 3 rats. 3In 2/3 groups at least one rat was dead fran injuries during observation. 
* P<0.05, *** P<0.005 significantly greater t.han 5.00 mg/kg apomorphine 
**P<0.025 significantly greater than 2.50 rrg/kg apJIDOrphine, Student's 
"t" Test . 
'! 
I 
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significantly rearing and vocalizations. Since, a dose of 
5.00 mg/kg apomorphine did not significantly increase ag-
gression intensity, but in fact decreased the intensity of 
both rearing and vocalizations compared to a dose of 2.50 
mg/kg apomorphine the one-hour aggression measurement was 
reanalyzed by breaking out the first JO minutes and the 
last JO minutes of the one hour of aggression measurement 
(note: during one hour of aggression measurement each par-
ameter was recorded at 10 minute intervals). Analysis of 
the first JO minutes of aggression after 2.50 or 5.00, mg/kg 
apomorphine showed that rats treated with 5.00 mg/kg apo-
morphine displayed significantly greater numbers of attacks 
and bites and significantly less vocalizations, while rear-
ing was not significantly increased compared to the ·first 
JO minutes of rats treated with 2.50 mg/kg apomorphine. 
During the last JO minutes of aggression measurement there 
, 
was no significant difference between attacks and bites, 
but rearing and vocalizations were significantly less in 
rats treated with 5.00 mg/kg apomorphine than in rats 
treated with 2.50 mg/kg apomorphine. Furthermore, in the 
first of the three groups treated with 5.00 mg/kg apomor-
phine one rat was dead within the first JO minutes, the 
other two were dead within the last JO minutes with none 
surviving the last 10 minutes of observation (death was 
due to the severe injuries sustained from bites received 
during intense aggression). In the second group of the 
::_ ..... ----~· 
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three treated with 5.00 mg/kg apomorphine one rat died dur-
ing the first JO minutes· leaving only two rats remaining 
during the last JO minutes of aggression measurement. In 
the third group treated with 5.00 mg/kg apomorphine no rats 
died during aggression measuremen~. A dose of 2.50 mg/kg 
apomorphine was selected for further studies with apomor-
phine-induced aggression in ethanol withdrawn rats (see 
discussion for interpretation of results). 
J. D-Amphetamine-Induced Aggression in Ethanol Withdrawn 
Rats 
D-Amphetamine was administered (i.p.) to rats with-
drawn 72 hours after inhalation of ethanol vapors (5 DAY 
HIGH) or to 'rats treated for 5 days with pyrazole (68 mg/kg/ 
day) or to rats administered only air in the inhalation 
chamber for 5 days. It was found that after administration 
of ct-amphetamine to ethanol withdrawn rats the most con-
sistent and intense aggression was · seen 60-120 minutes af-
ter injection . Therefore, this time period was selected 
for measurement of amphetamine-induced aggression. Table 
lJ summarizes the effects of various doses of d-ampheta~ 
mine administered to air-only controls, pyrazole controls 
and ethanol plus pyrazole treated and withdrawn rats. Un-
treated rats exposed to only air in the inhalation chamber 
were administered either J2 or 64 mg/kg ct-amphetamine in 
an attempt to induce aggression . No aggression was s~en 
' ' 
and a dose of 64 mg/kg ct-amphetamine administered to air-
. .!LL.. • .::.~-·-- --~-
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TABIE 13 
AMPHETAMINE-INDUCED AGGRESSION 
D-AMPHETAMINEl RESPONSES/HOUR (MEAN + S. E.) 
N2 TREATMENTS (MG/KG) A'ITACKS + BI'IES REARING VOCALIZATIONS 
AIR 32 4 0 + 0 0 + 0 6 + 3 
643 2 0 + 0 0 + 0 43 + 3 
AIR 4 4 0 + 0 0 + 0 7 + 3 
8 4 0 + 0 0 + 0 2 + 1 
16 4 0 + 0 0 + 0 6 + 1 
324 2 0 + 0 0 + 0 4 + 2 
l?YRAZOLE 644 2 0 + 0 0 + 0 16 + 1 
EI'HANOL 0 15 3 + 1 62 + 51 21 + 14 
+ 2 7 15 + 8** 1492 + 535*** 601 + 244** 
PYRAZOIE 4 6 36 + 7*** 1283 + 154*** 690 + 101*** 
1
.Aaministered (i. p.) after 72 hours of withdrawal 1 hour prior to ag-
gregati on, 5 DR! HIGH protocol. 
2N = number of groups, each group contains 3 rats. 
31.ethal to 5/6 rats tested. 
4r.ethal to 6/6 rats tested. 
*p < 0.05, ** P<0.001, *** P<0.0005 Student's "t" Test vs 0 mg/kg 
d-amphetam:i.ne. 
.. 
., .. , 
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only controls proved fatal to 5 of 6 of these rats. In 
rats administered only daily doses of pyrazole d-ampheta-
mine was administered at 4, 8, 16, 32 and 64 mg/kg, which 
also failed to induce aggression and proved fatal to all 
rats administered 32 or 64 mg/kg ct-amphetamine. However, . 
rats withdrawn 72 hours after inhalation of ethanol vapors 
ana administered either .2 or 4 mg/kg ~~amphetamine dis-
played aggression at levels significantly higher on all 
parameters of aggression compared to rats withdrawn from 
ethanol inhalation and administered saline. 
4. Protracted Drug-Induced Aggression in Ethanol Withdrawn 
Rats 
Rats which had previously fought at 72 hours of etha-
nol withdrawal after either apomorphine or ct-amphetamine 
were housed individually until "the seventh day of withdraw-
al. These rats were then administered either apomorphine 
(2.50 mg/kg, i.p.), ct-amphetamine (4.oo mg/kg, i.p.) or 
saline. Rats which had fought at 72 hours of ethanol. with-
drawal after apomorphine administration were administered 
apomorphine or saline on tne seventh day of withdrawal, 
while rats which had fought after ct-amphetamine at 72 hours 
of ethanol withdrawal were administered ct-amphetamine on 
the seventh day of withdrawal. Aggression was observed 
immediately after injection in rats administered apomor-
phine or saline and from 60-120 minutes after injection 
with ct-amphetamine a s was done at 72 hours OI ethanol with-
·---------' 
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drawal. Administration of either apomorphine or d-amphet-
amine to seven day ethanol withdrawn rats significantly in-
creased the in~ensity of all parameters of aggression when 
compared to rats which had fought at 72 hours of ethanol 
withdrawal after apomorphine, but administered only saline 
after seven days of ethanol withdrawal (see · Table 14). 
E) EFFECT OF DRUG TREATMENT ON APOMORPHINE-INDUCED AG-
GRESSION IN ETHANOL WITHDRAWN RATS 
1. Effect of Ethanol on Apomorphine-Induced Aggression in 
Ethanol Withdrawn Rats 
Table 15 summarizes the effect of orally administered 
ethanol in rats withdrawn for 96 hours after inhalation of 
ethanol vapors (5 DAY HIGH). A small number of groups of 
rats withdrawn from ethanol fail to display aggression 
after apomorphine (2.50 mg/kg, i.p.) at 72 hours of with-
drawal. Therefore, rats were tested at 72 hours of with-
drawal with a dose of 2.50 mg/kg apomorphine, if aggres-
sion was not seen within a JO-minute ·period, these groups 
were omitted from aggression studies at 96 hours of with-
drawal. Ethanol was administered o~ally at various doses 
JO minutes prior to administration of apomorphine (2.50 
mg/kg, i.p.) at 96 hours of ethanol withdrawal. The ana-
lysis of variance shows a significant effect of ethahoi 
on all parameters of apomorphine-induced aggression. Oral 
administration of ethanol at doses of 4.o and 8.0 g/kg 
s i gnfi c antly reduced apomorphine-induced aggression when 
... , • 
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TABLE 14 
DRUG-INDUCED AGGRESSION IN SEVEN DAY ETHANOL WITHDRAWN RATS 
DRUG1 RESPONSES/HOUR, MEAN + S.E. 
TREATMENT (MG/KG) N2 ATTACKS+ BITES REARING VOCALIZATIONS 
AIR 
+ APOMORPHINE 4 0 + 0 0 + 0 0 + 0 
(2. 50) - -PYRAZOLE 
ETHANOL SALINE 5 0 + 0 0 + 0 0 + 0 
- - -
APOMORPHINE 
+ (2. 50) 9 40 + 11 1328 + 324 911 + 284 
- - -
D-AMPHETAMINE 
PYRAZOLE (4.00) 5 46 + 14 1809 + 200 1087 + 260 
- - -
p3 p3 p3 
ETHANOL APOMORPHINE 
(2. 50) 9 < 0. 001 < 0. 001 (. 0.005 
+ 
D-AMPHETAMINE 
PYRAZOLE (4.00) 5 < 0. 01 < 0.0005 < 0.001 
lAdministered (i.p.) after 7 days of ethanol withdrawal in 
rats which fought at 72 hours of ethanol withdrawal (5 DAY HIGH). 
2N = Number of groups, each group contains 3 rats. 
3significantly greater than saline treated rats Student's 
"t" Test. 
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TABLE 15 
REDUCT'ION OF .APQM)RPHINE-INDUCED AGGRESSION BY ETHANOL 
RESPONSES/HOUR (MEAN + S .E.) ETHANOL1 
(G/KG) N2 ATI'AO<S + BITES REARING VOCALIZATIONS 
0 
0.5 
2.0 
4.0 
8.0 
8 
2 
2 
2 
2 
167 + 23 
129 + 35 
216 + 17 
23 + 23** 
l+ l** 
2669 + 121 1841 + 108 
2378 + 522 1373 + 103* 
2810 + 34 2012 + 90 
236 + 236** 54 + 54** 
2 + 2** 8 + 2** 
A.n.alysis of Variance of Attacks and Bites 
SOURCE 
OOSES 
ERROR 
'IDTAL 
SOORCE" 
OOSES 
ERROR 
'IDTAL 
SOURCE 
DOSES 
ERROR 
TOTAL 
d.f. SS .MS F 
4 
11 
15 
d. f. 
4 
11 
15 
82557 
32876 
115433 
20639 
2989 
Analysis of Variance of Rearing 
SS .MS 
19387860 4846965 
1474378 134034 
20862238 
6.91 
F 
36.16 
Analysis of Variance of Vocalizations 
d.f. 
4 
11 
15 
SS 
9765752 
694697 
10460449 
.MS 
2441438 
63154 
F 
33.66 
p 
< 0.005 
p 
< o. 005 
p 
< 0.005 
1
.Administered at 96 hours of withdrawal 30 min prior to Aparorphine (2.50 
mJ/kg, i.p.). Ethanol administered orally. 
2N = Number of groups, each group contains 3 rats. 
* P ( 0. 025; ** P < 0. 005 vs. 0 mJ/kg Ethanol 
___ ·: .. uL, . . . -~-- _. .. ___ __......_~----~-~ ... 
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compared to rats administered only apomorphine at 96 hours 
of ethanol withdrawal. 
2. Effect of Chlordiazepoxide on Apomorphine-Induced Ag-
gression in Ethanol Withdrawn Rats 
Table 16 summarizes the effect of administration of 
chlordiazepoxide (i.p.) on apomorphine-induced aggression. 
Chlordiazepoxide was administered JO minutes prior to ad-
ministration of apomorphine (2.50 mg/kg, i.p.) at 96 hours 
of ethanol withdrawal. The analysis of variance shows a 
significant effect of chlordiazepoxide on all parameters 
of apomorphine-induced aggression in ethanol withdrawn rats. 
Chlordiazepoxide administration at a dose of 40 mg/kg ~ig-
nificantly reduced the parameters of attacks and bites and 
vocalizations, while a dose of 80 mg/kg significantly re-
duced all parameters of apomorphine-induced aggression 
when compared to rats administered only apomorphine at 96 
hours of ethanol withdr9wal. 
J. Effect of Morphine Sulfate on Apomorphine-Induced Ag~ 
gression in Ethanol Withdrawn Rats 
Table 17 summarizes the effect of administration of 
morphine sulfate (i.p.) on apomorphine-induced aggression 
in ethanol withdrawn rats. Morphine sulfate was adminis-
tered JO minutes prior to administration of apomorphine 
(2.50 mg/kg, i.p.) at 96 hours of ethanol withdrawal. The 
analysis of variance shows a significant effect of morphine 
sulfate on all parameters of apomorphine~induced aggression 
_ .... 
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TABI.E 16 
REDUCTION OF APOMORPHINE-INDUCED AGGRESSICN BY CHLORDIAZEPOXIDE 
CHLORDIAZEPOXIDEl 
RESPONSES/HOUR (MEAN+ S.E.) 
(MG/KG) N2 ATI'ACKS + BITES REARING VOCALIZATION 
0 8 167 + 23 2669 + 121 1841 + 108 
10 3 137 + 49 2210 + 159 1776 + 291 
20 2 186 + 16 2267 + 161 1685 + 28 
40 2 74 + 14* 2712 + 648 588 + 212** 
80 2 4 + l** 110 + 18** 58 + l** 
Analysis of Variance of Attacks and Bites 
SCXJRCE d.f. SS MS F p 
DOSES 4 55966 13991 3.83 <. 0. 05 
ERROR 12 43851 3654 
TarAL 16 99817 
Analysis of Variance of Rearing 
SOURCE d.f. SS MS F p 
IX>SES 4 10991053 2747763 17.74 < 0.005 
ERROR 12 1858873 154906 
'IDT.AL 16 12849926 
Analysis of Variance of Vocalizations 
SOURCE d. f. SS MS F p 
OOSES 4 7006626 1751656 16.82 < 0. 005 
ERROR 12 1249607 104134 
TOT.AL 16 8256233 
1Administered at 96 hours of withdrawal 30 min prior to Apo:rrorphine (2.50 
J!l<J/kg, i.p.). Chlordiazepoxide administered intraperitoneally. 
2N = Number of groups, each group contained 3 rats. · 
* P < 0.05; ** P<0.005 vs. 0 m:J/kg Chlordiazepoxide. 
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TABLE 17 
REDUCTION IN APOMJRPHINE-INDUCED AGGRESSION BY MORPHINE 
MJRPHINE RESPONSES/HOUR (MEAN + S .E.) 
(MG/KG) N ATI'ACKS + BI'IES BEARING VOCALIZATIONS 
0 8 167 + 23 2669 + 121 1841 + 108 
5 3 149 + 10 2312 + 116* 1717 + 67 
10 2 5+ l** 108 + 22** 40 + 19* 
20 3 4 + 3** 87 + 52** 49 + 32** 
Analysis of Variance of Attacks and Bites 
SOURCE 
DOSES 
ERROR 
TOI'AL 
SCXJRCE 
DOSES 
ERROR 
TOI'AL 
SOURCE 
DOSES 
ERROR 
'IOTAL 
d.f. SS MS 
3 86584 28861 
12 29425 2452 
ls 116009 
Analysis of Variance of Rearing 
d.f. SS MS 
3 21352448 7117483 
12 914201 76183 
15 22266649 
Analysis of Variance of Vocalizations 
d.f. SS MS 
3 10700632 3566877 
12 685014 57085 
15 11385646 
F p 
11.77 < 0.005 
F p 
93.43 < 0. 005 
F p 
62.48 < 0. 005 
lAdministered at 96 hours of withdrawal 30 min prior to Ap:>rrorphine 
(2 • 50 ng/kg' i. p. } • 
2N = Number of groups, each group contains 3 rats. 
* P < 0. 05; ** P < 0. 005 vs. 0 ng/kg rrorphine sulfate. 
in ethanol withdrawn rats. Morphine sulfate administration 
at a dose of 5 mg/kg significantly reduced the aggression 
parameter of rearing, while doses of 10 mg/kg and 20 mg/kg 
of morphine sulfate significantly reduced all parameters 
of apomorphine-induced aggression in ethanol withdrawn rats 
when compared to rats administered only apomorphine at 96 
hours of ethanol withdrawal • 
. F) MORTALITY DURING ETHANOL WITHDRAWAL 
1. Mortality After Various Ethanol Exposure Protocols 
Table 18 summarizes the frequency of mortality occurr-
ing during withdrawal from ethanol after each of the three 
exposure protocols used in this study. Statistically none 
of the three protocols significantly changed the frequency 
of deaths during ethanol withdrawal. However, mortality 
occurring after exposure to the 5 DAY HIGH and 7 DAY HIGH 
protocols fell only slightly short of reaching significance 
(Chi square) vs 5 DAY LOW protocol. 
2. Mortality During Ethanol Withdrawal After Drug Treat-
ment During Ethanol Withdrawal 
Shown in the second part of Table 18 are the frequency 
(percentage) of mortality occurring during ethanol withdraw-
al in rats treated with either ethanol, chlordiazepoxide or 
morphine sulfate JO minutes prior to the thirty-sixth hour 
of ethanol withdrawa~. As was mentioned in the Experimental 
section of this thesis, mortality was recorded up to and in-
cluding the seventy-second hour of ethanol withdrawal. Rats 
:.'- .1l 0 tili. ..:.. 
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TABLE 18 
MORI'ALITY DURING ETHANOL WITHDRAWAL IN UNTREATED RATS AND RATS ADMINISTERED 
ETHANOL, CHI.DRDIAZEPOXIDE OR MJRPHINE DURING ETI-IANOL WITHDRAWAL 
TREATMENT N PERCENTAGE DEA'IlISl 
5 DE:l. I.1J.til 6 16.7 
5 DE:l. HIGH 48 20.8 
7 DE:l HIGH 18 44.4 
WITHDRAWAL2 
PERCENTAGE DFATHSl TREATMENI' DOSE 
ETHANOL 0.5 g/kg 41. 7 
2.0 g/kg 41. 7 
4.0 g/kg 50.0 
8.0 g/kg 8.3 
CHLORDIAZEPOXIDE 10 mg/kg 25.0 
20 mg/kg 25.0 
40 mg/kg 41. 7 
,80 mg/kg 33.3 
160 mg/kg 75.0* 
(160 mg/kg untreated 66.7) 
M)Rl?HINE . 10 mg/kg 16.7 
20 mg/kg 16.7 
40 mg/kg 8.3 
1Ethanol administered orally, chlordiazepoxide and m:::>rphine administered 
intraperitoneally 30 minutes prior to observation at 36 hours of ethanol 
withdrawal (5 DE:l. HIGH); N = 12 at each dose. 
2Total deaths occurring up to and including 72 hours of ethanol with-
drawal. 
* p < 0. 001 Chi square vs. 5 DAY HIGH. 
--~..1. 
undergoing untreated ethanol withdrawal were not observed 
to display any mortality after 72 hours of ethanol withdraw-
al nor were any rats treated during ethanol withdrawal. 
Seventy-two hours of ethanol withdrawal in rats treated dur-
ing ethanol withdrawal would correspond to J6 hours post-
injection. In most cases the number of animals was not suf-
ficient to achieve statistical significance and it was not 
feasible to increase the numbers solely for study of mor-
tality during ethanol withdrawal. However, in one extreme 
case a dose of 160 mg/kg chlordiazepoxide was administered 
which resulted in 75% mortality, which was significantly 
greater than rats withdrawn after exposure to the 5 DAY 
HIGH protocol and left untreated during ethanol withdrawal. 
Since, a dose of chlordiazepoxide 160 mg/kg proved to be 
significantly toxic to rats undergoing ethanol withdrawal, 
this s a me dose was administered (i.p . ) to untreated control 
rats. As can be seen in the second part of Table 18 a 
dose of chlordiazepoxi de 160 mg/kg administered intraperi-
toneally was also toxic to untreated rats resulting in the 
death of 66.7% of these rats by the thirty-sixth hour 
post-injection. There is no significant difference between 
the mortality seen in ethanol withdrawn rats and untreated 
rats a dministered a dose of 160 mg/kg chlordiazepoxide 
(i.p.) 
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DISCUSSION 
The development of tolerance to ethanol in alcoholis 
has been demonstrated (Isbell et al., 1955; Newman, 1941). 
However, the biochemical mechanisms subserving increased 
tolerance are unknown, but two general mechanisms have been 
postulated: an enhanced rate of metabolism and/or an in-
creased degree of cellular tolerance or adption to ethanol 
in the central nervous system. Both, experimental animals 
(Hawkins et al., 1966) and man (Mendelson~ al., 1966) de-
velop increased rates of ethanol metabolism following 
chronic administration. The increased ethanol metabolism 
in experimental animals has been correlated with increased 
hepatic alcohol dehydrogenase activity (Hawkins et~., 
1966; Mendelson~ al., 1965). However, changes in the 
rate of ethanol metabolism can not adequately explain the 
degree of tolerance observed (Mendelson, 1971). Further-
more, LeBlanc et al. (1969), showed that tolerance after 
several doses of ethanol was not associated with an in-
creased metabolic rate and suggested some form of cellular 
adaption as the basis of the tolerance seen. Sleeping time 
(narcosis) can be altered by increased elimination (Lal 
and Shah, 1968) and/or decreased sensitivity of the cen-
tral nervous system (ex. hyperexcitability) (Patel and Lal, 
1973). 
In our experiments tolerance to ethanol was measured 
as a reduction in the duration or an increase in the onset 
__ .:.~L~· ·- • _ ·-------~-,..j..J.b __ _:_c_~--
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of ethanol-induced narcosis in rats withdrawn 72 hours after 
continuous ethanol inhalation (5 DAY HIGH) at which time 
pyrazole administered during inhalation would be at neg-
ligible levels (Rydberg et al., 1972). Preliminary experi-
ments demonstrated that a dose of 5.5 g/kg, i.p. proved 
fatal to 6/8 rats treated, while a dose of 4.5 g/kg, i.p. 
induced narcosis in only 4/8 rats treated. Therefore, a 
dose of 5.0 g/kg, i.p. was selected for induction of· ethanol 
narcosis. Although, it is usually common practice to assign 
a maximum score to animals w~ich fail to recover, some ani-
mals died shortly after injection, while others never re-
covered and subsequently died. Since, the number of deaths 
in each experimental group (5/18 air + saline, 5/18 air + 
pyrazole and 6/23 ethanol + pyrazole) were similar these 
animals were omitted f rom the study. From a reduction in 
the duration of ethanol induced narcosis or an increase in 
onset time, as seen in our experiments, it is not possible 
to separate metabolic from c e llu J.ar tolerance. 
The occurrence of withdrawal signs upon cessation of 
ethanol administration is evidence of physical dependence. 
Inhalation of ethanol vapors along with daily injections 
of an alcohol dehydrogenase inhibitor pyrazole (68 mg/kg, 
i.p.) has been shown to produce ethanol physical depend-
ence in mice (Goldstein and Pal, 1971; Littleton~ al., 
1 9 74). Goldstein and Pal (1971), developed a method for 
rating the intensity of the ethanol withdrawal syndrome 
.,·. ' •• J 
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based upon several withdrawal signs in mice. This ethanol 
withdrawal intensity scale was subsequently used to ana-
lyze the effects of drugs on the alcohol withdrawal reac-
tion (Goldstein, 1972b.; 1973). Majchrowicz (1973), out-
lined the withdrawal signs in rats made physically depenq-
ent upon ethanol by daily intubations, but no .effort was 
made to measure their intensity. Although, Roach et al., 
(1973), categorized ethanol withdrawn rats, based upon the 
overall intensity, no effort was made to base the ranking 
upon the measurement of individual withdrawal signs. T~ere-
fore, we have developed a method for the measurement of 
the intensity of each withdrawal signs in rats made physi-
cally dependent on ethanol by continuous inhalation of 
ethanol vapors and daily injections of pyrazole. The in-
tensity of each of these withdrawal signs can subsequently 
be combined as a measurement of the intensity of the eth-
anol wi thdrawal syndrome, which can be used to · express the 
effects of drugs on the withdrawal reaction in rats. 
Unlike the development of alcoholism in man, the pro-
duction of physical dependence on ethanol in animals is 
very rapid, ranging from a few days (Goldstein and Pal, 
1971) to several months (Falk, 1972). Animal models of 
physical dependence on ethanol are generally classified as 
behavioral (self- administration) and pharmacological 
(forced-administration). Forced administration models pro-
vide a valua ble tool for assessing the end-product of 
-- ~L .. J. .. i._ -~....._ ·---.., 
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addiction, physical dependence. However, they afford little 
information about the factors which initiate and maintain 
drug administration as seen in human alcoholics. Implicit 
in this notion is the fact that behavioral models may prove 
more valuable in the future study of alcoholism. Forced-
administration models do provide information about the bio-
chemical and neurophysiological concomitants of alcohol de-
pendence which may prove valuable in the future in the de-
velopment of satisfactory behavioral models. 
For the purpose of this study, a modification of the 
technique developed by Goldstein and Pal (1971), was adopted. 
It shares the disadvantages common to all f6rced-administra-
tion models, but provides advantages which are lacking in 
most . Q~her models. The Goldstein-Pal model allows the 
production of relatively large numbers of dependent animals 
in short time, which are necessary for meaningful and prac-
tical experimental studies. Furthermore, the inhalation 
method provides t he production of an environment which is 
identical for all experimental subjects within a group, 
such that although chamber ethanol concentrations may vary 
somewhat from group to group all animals within an experi-
mental group are exposed to identical ethanol levels and 
only indivi dual biological variation can effect the with-
in g roup variation. 
Justification for the use of pyrazole is necessary. 
Pyrazole is known to produce liver toxicity (Lelbach, 1969; 
..... ,(1., . . . 
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Lieber et al., 1970) and its half-life in the body is in-
creased by ethanol administration (Rydberg et al., 1972). 
Pyrazole also has some synergistic action with ethanol on 
the central nervous system when the doses used are higher 
than those used in this research (Goldberg et al., 1972). 
Pyrazole, at the doses used in this research are several-
fold lower than the doses shown by Lester and Benson (1970), 
to be toxic in rats, therefore it is unlikely that pyrazole 
would produce toxic effects in our experiments. Further-
more, careful controlling of experiments should prevent 
against erroneous conclusions from synergistic actions of 
pyrazole and ethanol. Goldstein (1972a), used pyrazole to 
stabilize blood ethanol levels which markedly fluctuated 
when pyrazole was not used. These fluctuations resulted 
in high mortality during inhalation of ethanol vapors 
(Goldstein, 1972a). 
Roach~ al . (1973), produced physical dependence in 
rats using inhalation of ethanol vapors without pyrazole, 
however, the blood ethanol levels were highly variable as 
was the intensity of the withdrawal reaction. Large vari-
ability in the intensity of the withdrawal reaction induces 
unnecessarily high variability in the measurement of drug 
effects on the withdrawal reaction and tends to obscure 
signi ficant information about drug effectiveness in the 
t reatment of the ethanol withdrawal reaction. The method 
of Goldstein and Pal ( 1971) provides for control of this 
variability. 
" 
. " 
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Reliable detection of withdrawal signs as being pres-
ent or absent can be done accurately (Mello, 1973) and 
carefully developed rating scales, such as the one developed 
by Goldstein (1972a.) for mice, can provide valuable infer-
mation about the relative severity of the ethanol withdraw-
al reaction. Table 3 shows the ordinal rating scale used 
to measure the intensity of the ethanol withdrawal signs 
which are not readily measurable by quantitative measures. 
Statistically meaningful inferences can be made from rating 
or "ranking" scales using non-parametric analysis (Siegel, 
19 56) • 
Figure 8 represents the withdrawal intensity seen after 
three different exposure procedures carried out as prelimi-
nary experiments to determine the condi·tions sufficient for 
production of physical dependence. Goldstein (1972a), 
showed that the intensity of the alcohol withdrawal reaction 
was related to the total dose of alcohol administered. The 
results obtained in this study are in agreement with Gold-
stein's work, although no attempt was made to calculate the 
total dose of alcohol, since the overall purpose of this 
work was not comparison among treatments. This is supported 
by the following (see Table 1) : 1. the mean blood ethanol 
levels are significantly higher in 5 DAY HIGH and the first 
five days of the 7 DAY HIGH exposure protocols than in the 
5 DAY LOW protocol. 2. the higher blood ethanol levels re-
sulted in greater severity of the withdrawal reaction in 
. ,. 
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rats exposed to the 5 and 7 DAY HIGH protocols. The 5 DAY 
HIGH protocol was selected for subsequent studies because 
the degree of physical dependence was satisfactory and the 
mortality during ethanol withdrawal was not excessive (see 
Table 18). 
Goldstein (1972a.), reported weight loss in mice after 
either ethanol or pyrazole treatment, but did not report 
any results of both ethanol and pyrazole treatment on 
weight loss. Littleton et al. (1974), reported weight loss 
in mice after pyrazole treatment whether or not ethanol was 
administered, however he did report that there was no weight 
loss after ethanol alone. Table 4 demonstrates the effect 
of pyrazole or pyrazole plus ethanol on the body weight of 
rats after five days of treatment. Preliminary experiments 
carried out earlier agreed with Littleton's work. Rats 
exposed to only inhalation of ethanol vapors for five days 
did not lose body weight, but did prevent any gain in body 
weight over this period of time. As seen in Table 4 treat-
ment of rats with pyrazole or ethanol plus pyrazole re-
duced body weight, however, ethanol administration had a 
sparing effect on the pyrazole-induced body weight loss, 
possibly due to the caloric value of the inhaled ethanol. 
The withdrawal syndrome seen upon removal of a chronic-
ally administered physical dependence-producing drug is a 
dy namic process. Abstinence signs have been observed in 
man (Isbe l l et al., 1955; Mello and Mendelson, 1970) and 
.., ' , ' 
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in experimental animals (Goldstein, 1972a.), while bLood 
ethanol levels are still high. Majchrowicz (1973), has 
shown that the peak intensity of the withdrawal reaction 
occurs some time after blood ethanol levels fall to negli-
gible levels. Withdrawal signs specific to ethanol with-
drawal should follow similar changes in intensity as the 
duration of withdrawal increases. As seen in Figures 9a. 
and 9b. withdrawal signs seen after removal of rats from 
inhalation of ethanol vapors follows a similar time course 
of development in intensity. The peak intensity occurring 
at 36 hours after withdrawal. Headshakes occurring after 
withdrawal of rats from ethanol inhalation also follows a 
similar time course of development in intensity with the 
peak intensity occurring at 36 hours after withdrawal 
(see Figure 10). However, it can also be seen in Figure 
10 that headshakes are the only ethanol withdrawal sign 
observed to b9 associated with the administration of pyra-
zole alone at levels significantly greater than untreated 
control rats. Majchrowicz (1973), using an ethanol in-
tubation procedure without pyrazole for production of 
physical dependence in rats also reported shakes during 
ethanol withdrawal. Therefore, it is highly unlikely that 
pyrazole administration during ethanol inhalation is solely 
responsible for the increased occurrence of headshakes 
during ethanol withdrawal, although some synergistic ac-
tion may be involved. As seen in Figure 11 tail-lifts 
reach their peak intensity at 24 hours after ethanol with-
~ - r ' 
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drawal, however they do not decline significantly until 48 
hours after withdrawal, similar to the other ethanol with-
drawal signs. 
Withdrawal reactions follow when chronic administration 
of a dependence producing drug stops, and the signs of with-
drawal shou~d therefore be relieved by reinstating the same 
drug or its pharmacological equivalent. Goldstein (1972b.) 
and Ellis and Pick (1970b.), showed that ethanol does re-
duce the severity of the ethanol withdrawal reaction. Since , 
the mechanism of ethanol physical dependence and the subse-
quent withdrawal reaction are not known it is not clear 
which signs are specifically due to ethanol withdrawal. 
However, one may rule out signs which are not reduced by 
ethanol administration as being non-specific. As seen in 
Figures 12a. and 12b. all signs seen in rats after withdraw-
al from inhalation of ethanol vapors are significantly re-
duced by readministration of ethanol. Therefore, since 
all withdrawal signs follow a similar time course in in-
tensity development and are all reduced by readministration 
of ethanol the scores of the four ranked signs of piloerec-
tion, abnorma l posture, tremors and convulsions were com-
bined and summed for each rat tested to obtain a value 
representative of the in~ensity of the overall withdrawal 
syndrome. Figure 13 demonstrates the effect of readminis-
tration of ethanol on the ethanol withdrawal syndrome, 
r e presented as the median value of the sum of the four 
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ranked signs versus the dose of ethanol administered orally. 
As seen in Table 5 headshakes occurring during ethanol with-
drawal are also significantly reduced by readministration 
of ethanol. Tail-lifts as seen in Table 6 were also sig-
n i ficantly reduced by readministration of ethanol. There-
fore, all withdrawal signs observed and measur ed appear to 
be specifically related to the withdrawal or ethanol, al-
though there is some question as to what significance, if 
any, pyrazole has on the intensity of the headshakes seen 
during ethanol withdrawal, since pyrazole alone induces 
significantly higher frequencies of headshakes than ob-
served in untreat e d control rats. 
The use of chlordiazepoxide in the treatment of acute 
alcohol withdrawal in man is well established (Gross~ al . , 
1974). Chlordiazepoxide is also effective in reducing the 
severity of the ethanol withdrawal signs in animals (Gold-
stein, 1972b.). In our experiments chlordiazepoxide was 
also effective in reducing the severity of the ethanol with-
drawal reaction in rats. However, a dramatic increase in 
the mortality rate was seen after the highest dose of 
chlordiazepoxide administered (160 mg/kg, i.p . ). Goldstein 
(1972b.), also reported an increase in mortality in ethanol 
withdrawn mice after chlordiazepoxide (50 mg/kg, i.p.). The 
LD50 values for chlordiazepoxide in mice are 95 mg/kg (i.v.) , 
268 mg /kg (i.p.), 530 mg/kg (s.c.), 720 mg/kg (p.o.) and 
in rats 165 mg/kg (i.v.), 800 mg/kg (s.c.) and 2000 mg/ kg 
(p.o.) ( Barnes and Ellherington, 1 965). It has also been 
~ ... _ ·..w .. .J~ 
107· 
reported that 240 mg/kg/day (p.o.) chlordiazepoxide for 2 
years is well tolerated in rats (Zbinden, 1961) as well as 
100 mg/kg/day (i.p.) for five days (Hoogland, 1966). To 
my knowledge there has not been reported an LD50 value for 
intraperitoneally administered chlordiazepoxide in the rat. 
However , as can be seen the doses in the rat are 2-J times 
as great as for mice, therefore one would expect the Ln50 
for chlordiazepoxide (i.p.) to be somewhere in excess of 
500 mg/kg (i.p.). Therefore, on the basis of the known 
LD50 values a dose of chlordiazepoxide of 160 mg/kg (i.p.) 
should not produce the high mortality seen in ethanol with-
drawn rats. Since, animals undergoing ethanol withdrawal 
probably suffer from other disorders (ex. electrolyte im-
balance or fluid imbalance), which would normally be rou-
tinely handled in a clinical situation, these disorders may 
be at fault . However, in our experiments untreated con-
trols were also subjected to administration of chlordiaze-
poxide (160 mg/kg, i.p.) , which resulted in 66.7% mortality 
and was not significantly less than ethanol withdrawn rats 
administered the same dose of chlordiazepoxide. Male 
Long-Evans strain rats may be more sensitive to the toxic 
effects of chlordiazepoxide. 
Walsh et al. (1970), proposed that the formation of 
morphine-like alkaloids from tetrahydropapaveroline formed 
from dopamine and its aldehyde metabolite may be respon-
sible for the dependence liability of ethanol . This hy-
" . ' . ' ' 
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pothesis has been criticized by Goldstein and Judson (1971), 
when they failed to elicit naloxone-induced jumping, a 
morphine withdrawal sign, in ethanol dependent mice. In 
our experiments we have found that morphine administration 
during ethanol withdrawal significantly reduces the ethanol 
withdrawal syndrome in rats. Blockade of ethanol withdraw-
al signs by morphine, by itself, is not sufficient evidence 
to warrant the conclusion that these withdrawal signs are 
the result of dependence on morphine-like compounds formed 
during chronic ethanol administration. However, it is in-
teresting that some of the withdrawal signs seen during eth-
anal withdrawal are similar to those seen during morphine 
withdrawal in rats. Gianutsos et al. (1975), observed the 
- ,..._ 
following withdrawal signs in morphine withdrawn rats: 
piloerection, wet shakes (with occasional headshakes, 
Gianuts·os, personal communication), weight loss, hypothermia , 
ptosis, writhing and aggression, which is enhanced by apo-
morphine and amphetamine (Puri and Lal, 1973). In our ex-
periments with ethanol withdrawn rats piloerection, head-
shakes and aggression induced by apomorphine and d-amphet-
amine were observed. As proposed by Walsh et al. (1970) 
and Davis et al. (1970), the role, if any, that morphine-
like alkaloids have may be very limited and localized (ex. 
dopaminergic neurons), therefore, one would not expect all 
possible ethanol withdrawal signs to be related to these 
morphine-like compounds. Furthermore, non-specific effects 
l 1 \ I 
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of morphine, such as analgesia or resporatory depression 
may be involved in the effectiveness of morphine in reduc-
irtg the ethanol withdrawal syndrome in rats. Respiratory 
depression may be especially important in the light that 
convincing evidence for a role of respiratory alkalosis in 
the etiology of delirium tremens in humans (Victor, 1973). 
In order to more clearly establish a role for morphine-
like compounds in ethanol dependence the following condi-
tions should be tested in the future: 1. induction of eth-
anol withdrawal signs similar to morphine withdrawal signs 
without induction of specific ethanol withdrawal signs (ex. 
tremors and convulsions) by a narcotic antagonist in etha-
nol dependent rats. 2. isolation and identification of 
possible morphine-like compounds from animals dependent on 
ethanol. 3. production of dependence on these morphine-like 
compounds, which upon subsequent withdrawal would result in 
withdrawal signs similar to morphine-ethanol withdrawal 
signs (ex. aggression). Although, blockade of ethanol with-
drawal signs by morphine, by itself, . is not sufficient evi-
dence for a role for morphine-like compounds, failure to 
block ethanol withdrawal signs would have cast serious doubt 
on this hypothesis. However, the results of our experi-
ments indicate that further study appears warranted. 
Rats made physically dependent upon morphine show 
spontaneous aggression after withdrawal of morphine adminis-
tration (Puri and Lal, 1973). This spontaneous aggression 
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is enhanced by directly (apomorphine) and indirectly (amphet-
amine) acting dopamine receptor stimuJating agents and is 
blocked by the narcotic, methadone and the dopamine recep-
tor blocking neuroleptic haloperidol (Puri and Lal, 1973) • . 
Prior administration of alpha-methyl-para-tyrosine blocks 
the effect of amphetamine, but not apomorphine (Puri and 
Lai, 1973). These data were interpreted to indicate the 
presence of dopamine-receptor supersensitivity in morphine 
dependent and withdrawn rats. Apomorphine is a known sti-
mulator of dopamine receptors (Anden et al., 1967; Ernst, 
1967) and capable of producing aggression itself, but at 
doses several fold higher than needed to intensify mor-
phine withdrawal aggression (Gianutsos, 1974). It has al-
so been shown that chronic blockade of dopamine receptors 
by the neuroleptic, haloperidol, renders rats supersensi-
tive to small doses of apomorphine (Gianutsos et al., 1974a), 
which do not elicit aggression in normal animals (Gianutsos, 
1974). As seen in Table 11 the intensity of aggression in-
duced .by ·apomorphine in ethanol withdrawn rats increases 
with the duration of ethanol withdrawal. Apomorphine-in-
duced aggression in ethanol withdrawn rats was most intense 
at 72 hours of withdrawal. 
Table 12 summarizes the effect of the dose of apomor-
phine on apomorphine-induced aggression in 72-hour ethanol 
wi thd r a wn ra t s. However, the results were complicated by 
deaths occurring from injuries sustai ned during intense 
aggression aft er a dose of 5.0 mg/kg apomorphine. Examina-
··, .' , . .
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tion of the data in the usual man~er (total attacks and 
bites, rearing and vocalizations) shows that a dose of 2.5 
and 5.0 mg/kg of apomorphine significantly increased all 
parameters of aggression compared to rats administered on~ 
ly saline after 72 hours of ethanol withdrawal. Apomorphine 
does of 2.5 and 5.0 mg/kg also significantly increased all 
parameters of aggression when compared to a dose of 1.25 
mg/kg apomorphine. However, when apomorphine doses of 2.5 
mg/kg and 5.0 mg/kg are compared a dose of 5.0 mg/kg sig-
nifi~antly reduced all parameters of aggression, except at-
tacks and bites which were not significantly different. Ag-
gression was extremely intense after a dose of 5.0 mg/kg of 
apomorphine. It was observed that such intense attacking 
and biting occurred that few vocalizations and minimal rear-
jng were recorded. This aggression can be described as 
follows: Two rats would rear briefly or fail to rear and 
attack immediately; one rat would usually gain a dominant 
position and bite the other rat; the dominant rat would 
hold (while continuing to bite) the succumbed rat for long 
periods of time; when the dominant rat released its hold 
both rats would fall apart, as if stunned, then resume 
fighting or attack or be attacked by the third rat in the 
aggression group. Aggression as seen here is seldom co-
operative (2 against 1), but rather is on a one-to-one 
basis. 
This intense aggression resulted in the deaths of 
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several of these rats during aggression meaurement as de-
scribed in the results section. It is believed that the 
deaths and the intensity of the aggression, not the lack 
of it, was responsible for the decreased rearing and vocal-
izations seen after a dose of 5.0 mg/kg apomorphine. This 
is borne out in Table 12 where the data for aggression af-
ter 2.5 and 5.0 mg/kg of apomorphine in ethanol withdrawn 
rats is broken down into the first JO minutes and the last 
JO minutes of observation. During the first JO minutes 
rats administered 5.0 mg/kg of apomorphine had signifi-
cantly greater numbers of attacks and bites when compared 
to rats administered 2.5 mg/kg of apomorphine (40% increase), 
while rearing was not significantly different and vocali-
zations were significantly reduced. During the last JO 
minutes when several animals were either severely injured, 
dying or dead, attacks and bites are not significantly dif-
ferent and rearing and vocalizations are greatly reduced. 
A dose of 2.5 mg/kg of apomorphine was chosen for further 
studies, since·it produced intense aggression in ethanol 
withdrawn rats without the mortality following a dose of 
5.0 mg/kg of apomorphine. 
From this data it appears that while only very low 
levels of spontaneous aggression are seen in ethanol wiLh-
drawn rats, unlike morphine withdrawn rats, apomorphine 
i n smal l doses produces intense aggression in ethanol with-
drawn rats, similar to rats withdrawn after chronic 
·'. 
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haloperidol. Since, aggression seen after chronic treat-
ment of rats with morphine or haloperidol has been suggested 
to be due to latent supersensitivity of dopamine receptors, 
it would be of future interest to test the relationship be-
tween aggression in ethanol withdrawn rats and supersensi-
tivity of dopamine receptors. Induction of aggression by 
apomorphine in ethanol withdrawn rats is one indication of 
I 
dopamine receptor sensitivity. 
I Morphine withdrawal aggression is enhanced by adminis-
tration of amphetamine (Puri and Lal, 1973). As seen in 
Table 13 administration of ct-amphetamine to rats withdrawn 
from ethanol for 72 hours induces aggression. Interesting-
ly, doses of ct-amphetamine in non-ethanol exposed rats does 
not induce aggression, even when doses which were lethal 
were administered. These results indicate sensitivity to 
ct-amphetamine in ethanol withdrawn rats that can not be 
simulated in non-ethanol dependent rats, unlike apomorphine-
i n duced aggression. 
Gianutsos et al. (1974b.), showed that morphine with-
drawal a ggression was still present after protracted periods 
of withdra wal. As seen in Table 14 ethanol withdrawn rats 
remain sensitive to apomorphine and ct-amphetamine for at 
least seven days after withdrawal. These data again indi-
cate s'imilarities between ethanol and morphine withdrawal 
in rats. · 
As seen in Tables 15, 16 and 17 ethanol, chlordiaze-
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poxide and morphine, respectively, all reduced apcimorphine-
induced aggression in ethanol withdrawn rats. One would 
expect that if increased sensitivity to apomorphine in eth-
anol withdrawn rats is specifically related to chronic ad-. 
ministration of ethanol then readministration of ethanol 
or a drug, such as chlordiazepoxide, which is known to have 
cross-tolerance with ethanol, would antagonize apomorphine 
sensitivity. Furthermore, the effect of morphine in reduc-
ing apomorphine-induced aggression in ethanol withdrawn 
rats may be related to replacement of a morphine-like alka-
loid formed in or near dopamine neurons during chronic ad-
ministration of ethanol. This morphine-like alkaloid, 
through an action similar to morphine or haloperidol in 
blocking dopamine recep tors , could result in supersensitivity 
of dopamine receptors. 
Unfortunately, the effects of ethanol on neuroamine up-
take, storage and release of catecholamines in the central 
nervous system is not clear (Friedhoff and Miller, 1973) 
and many conflicting reports are present in the literature. 
Many of the conflicting results may stem from the differ-
ences occurring after acute compared to chronic administra-
tion of ethanol as well as the dosage administered (Fried-
hoff and Miller, 1973). One of the effects of acute eth-
anol administration to rats is the production of narcosis 
to which tolerance develops · (Friedhoff and Miller, 1973; 
this research). Administ ra tion of several biogenic amines, 
, I 
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including dopamine, has been shown to prolong ethanol nar-
cosis (Rosenfeld, 1960). Therefore, if increased mobiliza-
tion of dopamine or other catecholamines occurs in the 
mediation of ethanol-induced narcosis, then continuous ad-
ministration of ethanol might result in decreased production 
of dopamine by either repression of biosynthetic enzymes or 
negative feedback (Friedhoff and Miller, 1973). This could 
serve to reduce levels of available dopamine and restore 
normal levels of arousal in the face of continued ethanol 
administration (Friedhoff and Miller, 1973). This could 
also result in dopamine receptor sensitivity that would be 
unmasked upon cessation of ethanol administration. 
Recently, the conflicting reports on catecholamine 
turnover in the literature have been explained by Hunt and 
Ma·j chr owicz ( 1974). Hunt and Majchrowicz ( 1974), have 
shown that after a single oral dose of ethanol (5.0 g/kg) 
to rats the turnover of brain norepinephrine is increased, 
while the turnover of dopamine is unaffected during the 
first few hours after treatment. After the first few hours 
after ethanol administration the turnover of both nore-
pinephrine and dopamine are decreased (Hunt and Majchro-
wicz, 1974). In alcohol dependent rats, whe ~her intoxi-
cated or undergoing withdrawal, the turnover of norepine-
phrine is increased, while that of dopamine is decreased 
(Hunt and Ma jchrowicz, 1974). At this time the mechanism 
by which ethan ol may bring about these changes in catecho-
lami n e turnover is not known. However, an hypothesis of 
" . ..... - .... ___ ..._.,..~---!....... ...-
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adrenergic subsensitivity has been proposed by French et 
al. (1974), based upon the sustained release of norepine-
phrine by ethanol, as reported by Hunt and Majchrowicz 
(1974), and the reduced cyclic adenosine monophosphate re- -
sponse to norepinephrine in brain slices of rats chronically 
fed ethanol (French~ al., 1974). This hypothesis proposes 
that, since norepinephrine exerts an inhibitory effect in 
the brain which tends to limit the spread of audiogenic 
seizure discharge in the rats, then convulsions and tremors 
seen during ethanol withdrawal in rats may be due to the 
subsensitivity of adrenergic receptors in the brain. This 
statement has been supported by the evidence of Goldstein 
(1973), that drugs which deplete brain catecholamines or 
block alpha or beta receptors aggravates ethanol withdrawal 
seizures in mice. Furthermore, the aggression seen in eth-
anol withdrawn rats, as reported in this research, may be 
due to decreased turnover and release of dopamine, result-
ing in supersensitivity of dopa mine receptors, which is 
unmasked during ethanol withdrawal by the administration of 
the dopamine receptor stimulating agent apomorphine. The 
lack of s p ontaneous aggression during ethanol withdrawal 
may re f lect the decreased turnover of dopamine that occurs 
during chronic administ r ation of ethanol, which results in 
i ncreased sensitivity of dopamine receptors , but the con-
tinued decrease in turnover during withdrawal masks the 
sensitivity of dopa mine receptors even when ethanol is 
. '., 
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eliminated. Therefore, only by increasing dopamine release 
by ct-amphetamine or by direct stimulation of dopamine re-
ceptors by apomorphine does the sensitivity of dopamine 
receptors become apparent. Whether these effects on cate-· 
cholamine turnover after chronic administration of ethanol 
are due to direct effects of ethanol or its metabolite 
acetaldehyde or aberrant biogenic amine metabolites is un-
known. 
The model of ethanol physical dependence developed in 
this research provides a use::rul tool in the study of etha-
nol physical dependence by providing an animal model which 
is rapidly produced and responds relatively similar during 
ethanol administration and withdrawal as does man and also 
responds to drugs known to be useful in the treatment of 
alcohol withdrawal in man. Furthermore, aside from provid-
ing a useful model, this research has presented data which 
indicate that physical dependence on ethanol may have some 
relationship to physical dependence on morphine in rats and 
that drug dependencies in general may be related in ways 
not p~eviously recognized. 
,, 
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SUMMARY 
1. Rats exposed to continuous inhalation of ethanol vapors 
for 5 days showed an increase in the onset and a reduction 
in the duration of ethanol-induced narcosis. 
2. Withdrawal of rats after continuous inhalation of etha-
nol resulted in withdrawal signs: piloerection, abnormal 
posture, tremors convulsions, headshakes, tail-lifts and 
deaths. All signs reach maximum severity by J6 hours after 
ethanol withdrawal and return to near normal by 72 hours 
after withdrawal. All signs are reduced by ethanol read-
ministration during withdrawal. The occurrence of withdraw-
al signs and their reduction by ethanol represents the 
presence of ethanol physical dependence in these rats. All 
withdrawal signs follow a similar time course and were com-
bined into an ethanol withdrawal syndrome intensity measure-
ment. 
J. The ethanol withdrawal syndrome intensity was used to 
study the effect of chlordiazepoxide and morphine on the 
acute ethanol withdrawal reaction. Both chlordiazepoxide 
and morphine reduced the severity of the ethanol withdraw-
al reaction, however, chlordiazepoxide was toxic at a dose 
of 160 mg/kg. 
4. Aggressive behaviors were seen in ethanol withdrawn 
rats after small doses of apomorphine or ct-amphetamine. 
The peak intensity of drug-induced aggression was seen at 
--- ·--· --- ..• ·..l..J_L. ..... 
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72 hours of withdrawal. Ethanol, chlordiazepoxide and 
morphine reduced apomorphine-induced aggression in ethanol 
withdrawn rats. The mechanism underlying the sensitivity 
to apomorphine and amphetamine is unknown. 
5. De a ths during withdrawal were associated with induced 
and s p ontaneous seizures. Deaths were increased after a 
dose of chlordiazepoxide (160 mg/kg). Deaths resulting 
from factors other than seizures were probably also signif-
icant. 
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APPENDIX I 
SUM OF WITHDRAWAL SIGN INTENSITY RATINGS FOR PILOERECTION, 
ABNORMAL POSTURE, TREMORS AND CONVULSIONS 
HOURS OF ETHANOL WITHDRAWAL 
GROUP RAT # 0 12 24 36 48 72 
NAIVE 1 2 
2 2 
3 0 
4 l · 
5 2 
6 1 
7 2 
8 1 
9 1 
10 3 
11 1 
12 1 ' -
13 1 
14 1 
15 2 
16 1 
17 1 
18 0 
19 2 
20 1 
21 2 
22 1 
23 0 
24 2 
25 3 
26 2 
27 0 
28 1 
29 0 
30 2 
MEDIAN -r:-o 
PYRAZOLE 1 4 3 3 0 3 0 
+ 2 2 1 2 1 2 2 
AIR. 3 1 1 1 0 1 0 
4 3 1 1 1 0 3 
5 2 0 0 4 0 2 
6 1 0 0 2 0 0 
7 4 3 3 0 3 0 
8 2 2 1 1 2 2 
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APPENDIX I (continued) 
HOURS OF ETHANOL WITHDRAWAL 
GROUP RAT # 0 12 24 36 48 72 
PYRAZOLE 
+ 
AIR 9 3 3 2 1 · 2 2 
10 1 3 3 2 3 2 
11 3 3 3 1 3 1 
12 1 2 3 3 3 1 
13 2 1 1 0 1 3 
14 3 2 2 0 2 0 
15 3 1 0 1 0 2 
16 0 0 0 2 1 0 
17 0 0 0 2 0 1 
18 1 0 0 2 0 2 
MEDIAN 2:°0 1:0 1:0 1:0 1:5 1:5 
PYRAZOLE 1 0 4 5 D n.d. 
+ 2 0 2 5 5 3 n.d. 
ETHANOL 3 0 4 5 4. 4 n.d. 
5 DAY 4 0 2 3 3 1 n.d. 
LOW 5 0 3 4 3 2 n.d. 
6 0 2 3 3 2 n.d. 
MEDIAN 0-:0 2:5 4:-5 3:o 2:0 11:d. 
PYRAZOLE 1 2 5 6 9 5 n.d. 
+ 2 0 4 5 7 D n.d. 
ETHANOL 3 0 7 5 5 D n.d. 
5 DAY 4 2 5 5 8 10 n.d. 
HIGH 5 0 4 4 7 3 n.d. 
6 0 1 4 6 3 n.d. 
7 3 n.d. 8 n.d. 3 n.d. 
8 3 n.d. 7 n.d. 3 n.d. 
9 3 n.d. 7 n.d. 3 n.d. 
10 2 n.d. 7 n.d. 4 n.d. 
11 1 n.d. 5 n.d. 2 n.d. 
12 1 n.d. 4 n.d. 4 n.d. 
13 3 n.d. n.d. n.d. 6 n.d. 
14 3 n.d. n.d. n.d. 5 n.d. 
15 4 n.d. n.d. n.d. 4 n.d. 
16 3 n.d. n.d. n.d. 5 n.d. 
17 4 n.d. n.d. n.d. 5 n.d. 
18 1 n.d. n.d. n.d. 5 n.d. 
19 ' 3 5 6 12 D 
20 5 4 5 6 5 3 
21 0 6 5 7 6 3 
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APPENDIX I (continued) 
HOURS OF ETHANOL WITHDRAWAL 
GROUP RAT # 0 12 24 36 48 72 
22 0 1 5 8 8 D 
PYRAZOLE 23 0 2 6 6 3 5 
+ 24 2 5 7 6 6 4 
ETHANOL 25 1 3 5 10 D 
5 DAY 26 2 3 8 11 D 
HIGH 27 4 5 5 6 5 3 
28 3 4 4 5 4 4 
29 2 3 9 D 
30 0 2 3 5 4 3 
31 3 6 6 7 5 4 
32 1 4 4 5 8 5 
33 1 4 4 10 D 
34 2 3 6 6 3 5 
35 3 4 6 6 6 5 
36 2 3 3 4 4 3 
37 1 3 4 6 4 3 
38 3 3 5 7 5 4 
39 2 5 6 7 7 D 
40 0 3 4 5 4 3 
41 2 4 4 6 4 3 
42 3 3 5 5 D 
43 1 3 5 9 6 3 
44 0 3 4 5 5 4 
45 2 4 6 6 4 4 
46 2 3 4 6 6 4 
47 1 2 4 6 4 3 
48 1 1 5 5 4 4 
MEDIAN 2.0 3.5 5.0 6.0 4.5 4.0 
PYRAZOLE 1 n.d. n.d. 3 n.d. 5 n.d. 
z 2 n.d. n.d. 4 n.d. D n.d. 
ETHANOL 3 n.d. n.d. D n.d. n.d. 
7 DAY 4 n.d. n.d. 5 n.d. 3 n.d. 
HIGH 5 n.d. n.d. 7 n.d. D n.d. 
6 n.d. n.d. 4 n.d. 7 n.d. 
7 n.d. n.d. 3 6 D n.d. 
8 n.d. n.d. 5 4 n.d. n.d. 
9 n.d. n.d. 5 D n.d. 
10 n.d. n.d. 3 7 D n.d. 
11 n.d. n.d. 2 5 D n.d. 
12 n.d. n.d. 5 D n.d. 
APPENDIX I (continued) 
HOURS OF ETHANOL WITHDRAWAL 
GROUP RAT # 0 12 24 36 
PYRAZOLE 13 2 4 7 8 
+ 14 1 5 6 8 
ETHANOL 15 0 4 8 10 
7 DAY 16 1 3 3 6 
HIGH 17 3 5 6 9 
18 3 4 7 9 
MEDIAN 1. 5 4.0 5.0 7.5 
D = Died at some time prior to observation. 
- = Died during or prior to last observation 
123 
48 72 
2 n.d. 
8 n.d. 
3 n.d. 
4 n.d. 
5 n.d. 
7 n.d. 
5.0 n.d. 
n.d. = not done; all g~oups during preliminary experiments 
were not observed at all time periods. 
·,. 
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APPENDIX II 
PERCENT FREQUENCY OF WITHDRAWAL SCORES FOR WITHDRAWAL SIGNS IN 
RATS AFTER PYRAZOLE OR ETHANOL UNDER THE 5 DAY HIGH PARADIGM 
HOURS ·PILOERECTION SCORE 
PRETREATMENT WITHDRAWN STATISTICS 0 1 2 3 N 
PYRAZOLE 0 FREQ. 2 6 10 0 18 
% 11.1 33.3 55.6 0.0 
12 FREQ. 7 5 6 0 18 
% 38.9 27.8 33.3 o.o 
24 FREQ. 7 6 5 0 18 
% 38.9 33.3 27.8 0.0 
36 FREQ. 8 6 4 0 18 
% 44.4 33.3 22.2 o.o 
48 FREQ. 6 6 5 1 18 
% 33.3 33.3 27.8 5.6 
72 FREQ. 7 6 5 0 18 
% 38.9 33.3 27.8 o.o 
ETHANOL 0 FREQ. 12 15 17 4 48 
+ % 25.0 31. 2 35.4 8.3 
PYRAZOLE 12 FREQ. 2 10 22 2 36 
% 5.6 27.8 61.1 5.6 
24 FREQ. 0 3 31 8 42 
% 0.0 7.1 73.8 19.l 
36 FREQ. 0 1 21 13 35 
% 0.0 2.9 60.0 37.1 
48 FREQ. 0 4 31 5 40 
% 0.0 10.0 77.5 12.5 
72 FREQ. 0 3 17 2 22 
% 0.0 13.6 77.3 9.1 
ABNORMAL POSTURE SCORE 
0 1 2 3 N 
PYRAZOLE 0 FREQ. 8 6 4 0 18 
% 44.4 33.3 22.2 0.0 
12 FREQ. 10 7 1 0 18 
% 55.6 38.9 5.6 o.o 
24 FREQ. 11 6 1 0 18 
% 61.1 33.3 5.6 0.0 
36 FREQ. 10 8 0 0 18 
% 55.6 44.4 0.0 o.o 
48 FREQ. 12 5 1 0 18 
% 66.7 27.8 5.6 0.0 
72 FREQ. 11 7 0 0 18 
% 61. l 38.9 0. 0 . o.o 
ETHANOL 0 FREQ. 28 14 6 0 48 
+ % 58.3 29.2 12.5 o.o 
PYRAZOLE 12 FREQ. 1 14 19 2 36 
% 2.8 38.9 52.8 5.6 
24 FREQ. 1 4 24 13 42 ii. 
% 2 . 4 9 . 5 5 7 . 1 31. 0 
~·-· -!· . · ~--·------- -
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APPENDIX II (Continued) 
HOURS ABNORMAL POSTURE SCORE 
PRETREATMENT WITHDRAWN STATISTICS 0 1 2 3 N 
ETHANOL 36 FREQ. 0 1 14 20 35 
+ % o.o 2.9 40.0 57.1 
PYRAZOLE 48 FREQ. 0 9 27 4 40 
% 0.0 22.5 67.5 10.0 
72 FREQ. 0 8 14 0 22 
% 0.0 36.4 63.6 0.0 
TREMOR SCORE 
0 1 2 3 N 
J;'YRAZOLE 0 FREQ. 17 1 0 0 18 
% 94.4 5.6 0.0 0.0 
12 FREQ. 18 0 0 0 18 
% 100.0 o.o 0.0 o.o 
24 FREQ. 17 1 0 0 18 
% 94.4 5.6 0.0 0.0 
36 FREQ. 17 1 0 0 18 
% 94.4 5.6 0.0 0.0 
48 FREQ. 18 0 0 0 18 
% 100.0 0.0 0.0 0.0 
72 FREQ. 18 0 0 0 18 
% 100.0 0.0 0.0 0.0 
ETHANOL 0 FREQ. 48 0 0 0 48 
+ % 100.0 0.0 0.0 0.0 
PYRAZOLE 12 FREQ. 25 10 1 0 36 
% 69.4 27.8 2.8 0.0 
24 FREQ. 14 22 5 1 42 
% 33.3 52.4 11. 9 2.4 
36 FREQ. 5 16 8 6 35 
% 14.3 45.7 22.9 17.1 
48 FREQ. 19 16 5 0 40 
% 47.5 40.0 12.5 0.0 
72 FREQ. 19 3 0 0 22 
% 86.4 13.6 0.0 o.o 
CONVULSION SCORE 
0 1 2 3 N 
--l?YRAZOLE 0 FREQ. 18 0 0 0 18 
% 100.0 o.o 0.0 0.0 
12 FREQ. 18 0 0 0 18 
% 100.0 0.0 0.0 0.0 "" 
24 FREQ. 18 0 0 0 18 JI 
% 100.0 0.0 0.0 0.0 
,. 
36 FREQ. 18 0 0 0 18 
% 100.0 0.0 o.o o.o 
48 FREQ. 18 0 0 0 18 
% 100.0 o.o 0.0 0.0 
72 FREQ. 18 0 0 0 18 
% 100.0 o.o 0.0 0.0 
,. ___ , ----~~.~~ ' .··"·.' .' .~ I I' i \ ' 
-· ·--....... ~-----·· .... ----·-~-'-"...._....--~~.~-..... 
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APPENDIX II (continued) 
HOURS CONVULSION SCORE 
PRETREATMENT WITHDRAWN STATISTICS a 2 3 N 
ETHANOL 0 FREQ. 48 0 0 0 48 
+ % 100.0 o.o o.o 0.0 
PYRAZOLE 12 FREQ. 36 0 0 0 36 
% 100.0 0.0 0.0 0.0 
24 FREQ. 40 ' 0 1 1 42 
% 95.2 0.0 2.4 2.4 
36 FREQ. 30 0 1 4 35 
% 85.7 . 0.0 2.9 11. 4 
48 FREQ. 37 0 1 2 40 
% 92.5 0.0 2.5 5.0 
72 FREQ. 22 0 0 0 22 
% 100.0 0.0 0.0 0.0 
"' 
'I:• 
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APPENDIX III 
PERCENT FREQUENCY OF WITHDRAWAL SIGN SCORES AFTER DRUG 
ADMINISTRATION TO RATS WITHDRAWN 36 HOURS AFTER 
ETHANOL INHALATION 
PILOERECTION SCORE 
DRUG DOSE STATISTIC a 1 2 3 N 
SALINE l.a ml/kg FREQ. a 1 21 13 35 
% a.a 2.9 6a.a 37.1 
ABNORMAL POSTURE SCORE 
a 1 2 3 N 
FREQ. a 1 14 2a 35 
% a.a 2.9 4a.a 57.1 
TREMOR SCORE 
a 1 2 3 N 
FREQ. 5 16 8 6 35 
% 14.3 45.7 22. 9 17.1 
CONVULSION SCORE 
a 1 2 3 N 
FREQ. 3a a 1 4 35 
% 85.7 a. a 2. 9 11. 4 
PILOERECTION SCORE 
a 1 2 3 N 
ETHANOL a.5 g/kg FREQ. a a 5 6 11 
% a.a a.a 45.4 54.5 
2. a g/kg FREQ. 1 a 6 3 la 
% la.a a.a 6a.a 3a.a 
4. a g/kg FREQ. 1 1 5 4 11 
% 9.1 9.1 45.4 36.4 
8.a g/kg FREQ. 3 4 4 a 11 
% 2 7. 3 36.4 36.4 a.a 
ABNORMAL POSTURE 
a 1 2 3 N 
a.5 g/kg FREQ. a a 8 3 11 
% a.a a.a 72.7 2 7. 3 
2. a g/kg F REQ. a 3 5 2 la 
% a.a 3a.a 5a.a 2a.a 
4.a g/kg FREQ. 3 5 3 a 11 
% 27.3 45.4 27. 3 a.a 
8.a g/kg FREQ. 9 2 a a 11 
% 81. 8 18.2 a.a a.a 
-~-----..........---·---
. j , .. 
-~----...._.,:--'----~-----·--·-
'·,; t 
_ __,_ ...__ _______ _ 
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APPENDIX III (continued) 
TREMOR SCORE 
DRUG DOSE STATISTIC 0 1 2 3 N 
0.5 g/kg FREQ. 4 3 1 3 11 
ETHANOL % 36.4 27.3 9. 1 27.3 
(cont.) 2. 0 g/kg FREQ. 8 1 1 0 10 
% 80.0 10.0 10.0 0.0 
4.0 g/kg FREQ. 10 1 0 0 11 
% 90.9 9. 1 0.0 o.o 
8.0 g/kg FREQ. 11 0 0 0 11 
% 100.0 0.0 0.0 o.o 
CONVULSION SCORE 
0 1 2 3 N 
0.5 g/kg FREQ. 7 0 2 . 2 11 
% 63.6 0.0 18.2 18.2 
2. 0 g/kg FREQ. 10 0 0 0 10 
% 100.0 0.0 0.0 0.0 
4.0 g/kg FREQ. 11 0 0 0 11 
% 100.0 0.0 o.o o.o 
8.0 g/kg FREQ. 11 0 0 0 11 
% 100.0 0.0 o.o o.o 
PILOERECTION SCORE 
0 1 2 3 N 
CHLORDI-10 mg/kg FREQ. 0 0 6 6 12 
AZEPOXIDE % 0.0 o.o 50.0 50.0 
20 mg/kg FREQ. 0 0 2 8 10 
% 0. 0 0.0 20.0 80.0 
40 mg/kg FREQ. 0 2 8 2 12 
% 0. 0 16.7 66.7 16.7 
80 mg/kg FREQ. 0 5 4 3 12 
% 0. 0 41. 7 3 3. 3 25.0 
160 mg/kg FREQ. 5 5 2 0 12 
% 41. 7 41. 7 16.7 o.o 
ABNORMAL POSTURE SCORE 
0 1 2 3 N 
10 mg/kg FREQ. 0 0 8 4 12 
% o.o 0. 0 66.7 3 3. 3 
20 mg/kg FREQ. 0 0 8 2 10 
% 0. 0 0. 0 80.0 20.0 
40 mg/kg FREQ. 0 3 4 5 12 
% o.o 25.0 3 3. 3 41. 7 
80 mg/kg FREQ. 3 2 7 0 12 
% 25.0 16.7 58.3 0.0 
160 mg/kg FREQ. 12 0 0 0 12 
% 100.0 0. 0 0.0 o.o 
' . 
·~--- _ _;_.o,...__ _ _ , ___ - -
- _ ... -- ---~--..... -"---~.-...1 
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APPENDIX III (continued) 
TREMOR SCORE 
DRUG DOSE STATISTIC 0 1 2 3 N 
10 mg/kg FREQ. 4 4 4 0 12 
% 3 3. 3 3 3. 3 3 3. 3 o.o 
20 mg/kg FREQ. 4 4 2 0 10 
% 40.0 40.0 20.0 0.0 
40 mg/kg FREQ. 6 4 2 0 12 
% 50.0 33.3 16.7 o.o 
8 mg/kg FREQ. 8 2 2 0 12 
% 66 . 7 16.6 16.7 0.0 
160 mg/kg FREQ. 12 0 0 0 12 
% 100.0 o.o 0.0 o.o 
CHLORDIAZEPOXIDE 
(cont.) CONVULSION SCORE 
(') 1 2 3 N 
10 mg/kg FREQ. 9 0 1 2 12 
% 75.0 o.o 8.3 16.7 
20 mg/kg FREQ. 8 0 1 1 10 
% 80.0 0.0 10.0 10.0 
40 mg/kg FREQ. 12 0 0 0 12 
% 100.0 0.0 0. 0 0.0 
80 mg/kg FREQ. 12 0 0 0 12 
% 100.0 0.0 0.0 o.o 
160 mg/kg FREQ. 12 0 0 0 12 
% 100.0 o.o 0.0 0.0 
PILOERECTION SCORE 
0 1 2 3 N 
MORPHINE 10 mg/kg FREQ. 0 0 11 1 12 
% o.o o.o 91. 7 8. 3 
20 mg/kg FREQ. 0 1 9 2 12 
% 0.0 8. 3 75.0 16.7 
40 mg/kg FREQ. 4 5 2 0 11 
% 36.4 45.4 18.2 o.o 
ABNORMAL POSTURE SCORE 
0 1 2 3 N 
10 mg/kg FREQ. 1 3 8 0 12 
% 8. 3 25.0 66.7 o.o 
20 mg/kg FREQ. 3 5 3 1 12 
% 25.0 41. 7 25. 0 8. 3 
40 mg/kg FREQ. 11 0 0 0 11 
% 100.0 0.0 0.0 o.o 
:~ ............. ~-
....... -- ----~ -LL1.Ll. -· -· ----
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APPENDIX III (continued) 
TREMOR SCORE 
DRUG DOSE STATISTIC 0 1 2 3 N 
MORPHINE 
(cont.) 10 mg/kg FREQ. 5 3 4 0 12 
% 41. 7 25.0 3 3. 3 o.o 
20 mg/kg FREQ. 7 4 1 0 12 
% 58.3 33. 3 8. 3 o.o 
40 mg/kg FREQ. 11 0 0 0 11 
% 100.0 0.0 0.0 o.o 
CONVULSION SCORE 
0 1 2 3 N 
10 mg/kg FREQ. 10 0 1 1 12 
% 83.3 o.o 8. 3 8. 3 
20 mg/kg FREQ. 12 0 0 0 12 
% 100.0 o.o 0.0 o.o 
40 mg/kg FREQ. 11 0 0 0 11 
% 100.0 0.0 0. 0 o.o 
r1., ·' 
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APPENDIX IV 
SUM OF WITHDRAWAL SIGN INTENSITY RATINGS FOR PILOERECTION, AB-
NORMAL POSTURE, TREMORS AND CONVULSIONS MEASURED AT 36 HOURS 
OF ETHANOL WITHDRAWAL AFTER ETHANOL, CHLORDIAZEPOXIDE OR MOR-
PHINE PRETREATMENT 30 MINUTES PRIOR TO OBSERVATION. 
DOSAGE 
1 ml/kg 1 ml/kg 1 ml/kg 1 ml/kg 
PRETREATMENT RAT SCORE RAT SCORE RAT SCORE RAT SCORE 
SALINE 1 9 13 n.d. 25 10 37 6 
2 7 14 n.d. 26 11 38 7 
3 5 15 n.d. 27 6 39 7 
4 8 16 n.d. 28 5 40 5 
5 7 17 n.d. 29 D 41 6 
6 6 18 n.d. 30 5 42 5 
7 n.d. 19 12 31 7 43 9 
8 n.d. 20 6 32 5 44 5 
9 n.d. 21 7 33 10 45 6 
10 n.d. 22 8 34 6 46 6 
11 n.d. 23 6 35 6 47 6 
12 n. d. 24 6 36 4 48 5 
MEDIAN 6.0 
DOSAGE 
0,5 9:/kg 2. 0 g/kg 4.0 g/kg 8.0 g/kg 
ETHANOL RAT SCORE RAT SCORE RAT SCORE RAT SCORE 
1 10 13 3 25 5 37 1 
2 5 14 D 26 3 38 2 
3 D 15 5 27 3 39 0 
4 8 16 1 28 4 40 IT' 
5 5 17 5 29 4 41 2 
6 6 18 8 30 4 42 0 
7 7 19 5 31 3 43 2 
8 6 20 4 32 D 44 1 
9 6 21 4 33 4 45 2 
10 12 22 5 34 5 46 2 
11 8 23 3 35 1 47 0 
12 4 24 D 36 0 48 2 
MEDIAN 6 .0 4.5 4.0 2.0 
-,, 
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APPENDIX IV (continued) 
DOSAGE 
10 mg£'.'.kg 20 m;i/kg 40 m;i/k9: 80 mg/kg 160 m9/k9: 
CHLORDI- RAT SCORE RAT SCORE RAT SCORE RAT SCORE RAT SCORE 
AZEPOXIDE 
1 5 13 7 25 5 37 5 49 0 
2 8 14 4 26 6 38 4 50 1 
3 8 15 6 27 5 39 3 51 2 
4 7 16 5 28 3 40 2 52 0 
5 7 17 D 29 7 41 3 53 1 
6 5 18 10 30 2 42 5 54 0 
7 4 19 D 31 3 43 3 55 1 
8 10 20 6 32 6 44 5 56 0 
9 5 21 6 33 5 45 3 57 1 
10 8 22 8 34 7 46 4 58 1 
11 7 23 7 35 5 47 1 59 2 
12 4 24 4 36 4 48 6 60 0 
-- · MEDIAN 7. 0 6.0 5.0 3. 5 1. 0 
DOSAGE 
10 mg/kg 20 mg/kg 40 mg/kg 
RAT SCORE RAT SCORE RAT SCORE 
MORPHINE 1 2 13 3 25 1 
2 4 14 4 26 D 
3 9 15 5 27 1 
4 6 16 3 28 0 
5 5 17 4 29 2 
6 3 18 7 30 1 
7 4 19 2 31 0 
8 3 20 1 32 1 
9 5 21 3 33 0 
10 5 22 5 34 2 
11 6 23 2 35 0 
12 8 24 6 36 1 
MEDIAN 5.0 3 . 5 1. 0 
I ' 
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